ACS Publications. Most Trusted. Most Cited. Most Read
Is Supramolecular Filament Chirality the Underlying Cause of Major Morphology Differences in Amyloid Fibrils?
My Activity

Figure 1Loading Img
  • Open Access
Article

Is Supramolecular Filament Chirality the Underlying Cause of Major Morphology Differences in Amyloid Fibrils?
Click to copy article linkArticle link copied!

View Author Information
Department of Chemistry, University at Albany, State University of New York, 1400 Washington Avenue, Albany, New York 12222, United States
BioTools, Inc., 17546 Bee Line Highway, Jupiter, Florida 33458, United States
§ Department of Biological Sciences and Center for Structural Biology, Vanderbilt University, Box 351634 Station B, Nashville, Tennessee 37235, United States
Department of Chemistry, Syracuse University, 1-014 Center for Science and Technology, Syracuse, New York 13244, United States
Open PDFSupporting Information (1)

Journal of the American Chemical Society

Cite this: J. Am. Chem. Soc. 2014, 136, 6, 2302–2312
Click to copy citationCitation copied!
https://doi.org/10.1021/ja407583r
Published January 9, 2014

Copyright © 2014 American Chemical Society. This publication is licensed under these Terms of Use.

Abstract

Click to copy section linkSection link copied!

The unique enhanced sensitivity of vibrational circular dichroism (VCD) to the formation and development of amyloid fibrils in solution is extended to four additional fibril-forming proteins or peptides where it is shown that the sign of the fibril VCD pattern correlates with the sense of supramolecular filament chirality and, without exception, to the dominant fibril morphology as observed in AFM or SEM images. Previously for insulin, it has been demonstrated that the sign of the VCD band pattern from filament chirality can be controlled by adjusting the pH of the incubating solution, above pH 2 for “normal” left-hand-helical filaments and below pH 2 for “reversed” right-hand-helical filaments. From AFM or SEM images, left-helical filaments form multifilament braids of left-twisted fibrils while the right-helical filaments form parallel filament rows of fibrils with a flat tape-like morphology, the two major classes of fibril morphology that from deep UV resonance Raman scattering exhibit the same cross-β-core secondary structure. Here we investigate whether fibril supramolecular chirality is the underlying cause of the major morphology differences in all amyloid fibrils by showing that the morphology (twisted versus flat) of fibrils of lysozyme, apo-α-lactalbumin, HET-s (218–289) prion, and a short polypeptide fragment of transthyretin, TTR (105–115), directly correlates to their supramolecular chirality as revealed by VCD. The result is strong evidence that the chiral supramolecular organization of filaments is the principal underlying cause of the morphological heterogeneity of amyloid fibrils. Because fibril morphology is linked to cell toxicity, the chirality of amyloid aggregates should be explored in the widely used in vitro models of amyloid-associated diseases.

Copyright © 2014 American Chemical Society

Introduction

Click to copy section linkSection link copied!

Specific fibril aggregation of more than 20 proteins has been linked to a pathogenesis of many amyloid-associated diseases such as Alzheimer’s disease, Parkinson’s disease, Huntington’s diseases, and prion diseases. (1-3) Moreover, a formation of amyloid-like fibrils takes place in other maladies associated with protein misfolding, including diabetes type II, prolactoma, primary amyloidosis, etc. (4, 5) Striking evidence has recently accumulated suggesting that the ability to form amyloid fibrils is not a peculiarity of this small group of disease-related proteins but, rather, the ability to form amyloid is a generic property of the polypeptide chain. (6) Amyloid fibrils are β-sheet rich protein aggregates with different morphologies that constitute a phenomenon known as fibril polymorphism. (7, 8)In vitro aggregation of various amyloid associated proteins, such as calcitonin, (9) amylin, (10) insulin, (8) transthyretin, (11) and mouse prion, (12) commonly leads to the formation of two distinct fibril morphologies: tape-like and helical-twisted. Microscopic examination of post-mortem extracted amyloids from brains of patients who were diagnosed with Alzheimer’s disease also revealed both of these fibril polymorphs. (13, 14) It has also been demonstrated that fibril morphology directly correlates with cell toxicity. (12, 15) Thus, a controllable formation of one fibril polymorph versus another could possibly slow down fibril development and progression of various amyloid associated disorders. At the same time, the factors leading to one fibril polymorph or another are not currently known. It has also been observed that, with protein aggregation, many physical and chemical factors, such as ionic strength, (16) temperature, or pressure, (7) determine the fibril structure and morphology. For example, Makarava and Baskakov found that hamster cellular isoform of mammalian prion protein forms variable fibril polymorphs under different aggregation conditions. (2) Separately, Petkova et al. observed that agitation of Aβ peptide solution results in the formation of structurally and morphologically different fibril polymorphs compared to the fibrils formed without agitation. (17) These fibril polymorphs of Aβ had different cell toxicity. A few years ago, Dzwolak demonstrated that vortexing of insulin solutions during protein aggregation at 60 °C causes the formation of fibril superstructures exhibiting negative induced circular dichroism (−ICD) upon binding the achiral dye, thioflavin T (ThT). (18) If, however, the same fibrillation was carried out at a temperature, below 50 °C, randomly two differing supramolecular structures were obtained that showed opposite ICD (−ICD and +ICD polymorphs). (19, 20) Insulin fibrils that were not agitated, while being formed, did not exhibit any ICD signal. Interestingly, the morphologies of the two observed chiral polymorphs although similar showed a tendency for more lateral alignment of filaments for the +ICD polymorph compared to the −ICD polymorph. (19, 20) This discovery emphasized the importance of utilizing alternative methods beyond classical microscopy, such as AFM (atomic force microscopy) and SEM (scanning electron microscopy), that are capable of distinguishing chiral fibril polymorphs that otherwise appear identical.
Recently, it was discovered that VCD (21) is a unique tool that can directly probe supramolecular fibril chirality in solution as well as in dried films. (22) Studies of insulin fibrils indicated that enhanced VCD sensitivity arises directly from the long-range supramolecular chirality of fibril structures at all hierarchical levels. It was shown that VCD probes deeper levels of fibril supramolecular chiral organization that are not apparent using existing forms of microscopy. In particular, we found that insulin aggregation at pH 2.4 and higher results in the formation of fibrils that show a strong VCD spectrum with peaks near 1554, 1593, 1627, 1647, 1670 cm–1, which have a sign pattern (+ + – + +). (22, 23) We named this sign pattern and its associated chiral polymorph “normal”. Microscopic examination of these fibrils indicated that a majority of them have a left-handed helical twist. (24) However, if the pH of the aggregation solution is lower than 2.4, the distribution of fibrils shifts to increasingly flat, tape-like, or binary fibrils as the incubation pH continues to be lowered that under microscopic examination show no noticeable chirality or twist on their surface. Nevertheless, these fibrils show a strong, but often somewhat smaller, VCD with a sign pattern (− – + – −) that is nearly the mirror-image of “normal” VCD fibril spectrum and is referred to as the “reversed” polymorph. The fact that flat tape-like fibrils show a strong reversed VCD signal indicates that they must be composed of right-handed filaments, the chirality of which lies below the limit of AFM or SEM detection. Our combined VCD-microscopic studies showed that pH determines not only the net handedness of the filaments, precursors of mature fibrils, but also controls their association pathways. (24) Left-handed filaments intertwine, forming left-handed proto-fibrils and mature fibrils that have normal VCD. On the other hand, right-handed filaments associate side-by-side, forming flat, tape-like, or binary fibrils. Thus, pH most likely alters protein–solvent interactions or causes protonation of some amino acid side chains, which are lying on the surface of the filaments. These changes cause variations in the way these filaments bind together to form mature fibrils that either twist together to form braids or align side-by-side without braiding. In addition, it was discovered that that pH not only determines insulin fibril morphology and net chirality at the stage of the protein aggregation, but also may dramatically change the morphology of mature fibrils and overturn their initial chirality. (25)
The key question we answer in this paper is whether the supramolecular chirality of the filaments is the underlying cause of morphological differences only for insulin fibrils, or whether it is a more general phenomenon that determines the polymorphism of other amyloidogenic proteins and peptides. A related question is whether the supramolecular chirality of all fibril filaments can be controlled by pH. To address these questions we studied aggregation as a function of incubation pH for hen-egg lysozyme, bovine apo-α-lactalbumin, HET-s (218–289) prion-forming domain from fungus Podospora anserina, and a short 11-residue peptide fragment of human transthyretin (TTR (105–115)). The intrinsic supramolecular chirality of these fibrils was measured by VCD, and in parallel, fibril morphology was characterized by atomic force microscopy (AFM), scanning electron microscopy (SEM), and cryo-SEM. In addition the secondary structure of each of these amyloid fibrils was determined by Fourier transform infrared (FTIR) and deep UV resonance Raman (DUVRR) spectroscopy.

Results

Click to copy section linkSection link copied!

Lysozyme

Lysozyme, like insulin, forms opposite chiral polymorph depending on the incubation pH. Hen-egg lysozyme is a widely used model protein for amyloidogenic studies that aggregates at low pH and high temperatures, forming rod-like fibrils. (26-28) Previously, it was reported that lysozyme forms fibrils that show enhanced “normal” VCD. (22) Here, hen-egg lysozyme (60 mg/mL) was incubated at 65 °C for 3 days at different pH values. Protein aggregation was terminated by reducing the sample to room temperature. The solution was centrifuged at 10 000 rpm for 20 min, and the resulting gelatinous solution, dominated by mature fibrils, was analyzed by IR and VCD (Figure 1).

Figure 1

Figure 1. VCD (a) and IR (b) spectra of lysozyme fibrils grown at pH 1.0 (blue), 1.5 (green), 2.3 (black), and 2.7 (red) for 3 days at 65 °C.

The strong peak at 1623 cm–1 in the IR spectra of all studied samples indicates a dominance of β-sheet structure (Figure 1, bottom). (29) The peak at 1663 cm–1 that increases in intensity with increasing pH is associated with nonordered or loop structure, (30) and may be related to the rate of fibril formation during the specified incubation conditions.
We found that relatively small variations in the pH of the aggregation solution cause dramatic changes in the VCD spectra of lysozyme fibrils, the largest of which is almost 10 times more intense than the corresponding intense VCD spectra observed for insulin fibrils grown under the same pH values. (23) As is evident from the VCD spectra, lysozyme fibrils show normal VCD at pH 2.7 (Figure 1) and higher (data not shown). Fibrils that were grown at low pH (1.0–1.5), on the other hand, show reversed VCD with intensity comparable in magnitude but roughly opposite in sign compared to normal VCD. Fibrils that were grown at pH 2.3 have very weak VCD intensity, with small residual VCD peaks for both normal (negative, 1610 cm–1) and reversed (positive, 1624 cm–1) fibrils present. One therefore concludes that pH 2.3 is close to an equilibrium balance point in the distribution of normal and reversed lysozyme fibrils. Similar VCD spectral patterns were obtained for insulin fibrils grown at the same pH values. (23)
We also investigated whether prolonged aggregation at elevated temperature causes any changes in lysozyme fibrils. Solutions with pH from 1.0 to 2.7 (60 mg/mL) were incubated at 65 °C for 5 days, and their VCD and IR spectra were recorded (Supporting Information Figure S1). We found that VCD intensity of all fibril solutions, except the very small VCD intensity from fibrils incubated at pH 2.3, decreased compared to fibrils grown for 3 days at 65 °C. In addition to the decrease of VCD intensity we found that the position of a negative peak changed: lysozyme fibrils that were grown at pH 2.7 had a negative peak at 1610 cm–1 (3 days of incubation) and at 1616 cm–1 (5 days of incubation). The same band minimum shifted from 1610 cm–1 to 1623 cm–1 for lysozyme fibrils grown at pH 2.3. These changes will be considered further in the Discussion section.
Fluid-cell AFM and SEM were utilized to investigate morphological differences between normal and reversed lysozyme fibrils. Both AFM and SEM (but not TEM) microscopy can provide information about the sense, or handedness, of fibril helical chirality. (30)
AFM and SEM are complementary microscopic methods for the determination of accurate species dimensions: AFM provides accurate height data, while width dimensions may be larger due to a finite tip-width convolution error. SEM, on the other hand, may not be utilized for height determination, but does provides accurate width data. Images of reversed and normal lysozyme fibrils are shown in Figure 2. We found that lysozyme fibrils that exhibit reversed VCD have a flat tape-like morphology without a noticeable twist. They have a height between 2.5 and 3.0 nm and a width in the range of 25 nm. Some of these fibrils are composed of two side-to-side associated fibrils (Figure 2, b). Lara et al. reported that these tape-like lysozyme fibrils consist of as many as 17 laterally assembled filaments. (31) According to our data, binary lysozyme fibrils have the same height as the discussed tape-like fibrils, while their width is significantly larger (∼45 nm). Lysozyme fibrils that exhibit normal VCD have cylindrical shapes. Some of these fibrils exhibit a well-defined left-handed twist (Figure 2, c; identified by yellow arrows). They have a height between 6 and 8 nm and a width between 18 and 20 nm. As with insulin, (23, 24) lysozyme fibrils exhibiting normal and reversed VCD have cylindrical left-twisted and flat tape-like fibril morphologies, respectively.

Figure 2

Figure 2. SEM (a, c) and fluid-cell AFM (b, d) images of reversed VCD (a, b) and normal VCD (c and d) lysozyme fibrils grown at 65 °C for 3 days. Helical twisted fibrils (all left-handed) are indicated by yellow arrows. Scale bars are 100 nm.

It is interesting that neither for insulin nor lysozyme fibrils exhibiting reversed VCD is there any evidence of right-handed twist on their surface. One might suspect that fibril dehydration after fixation on copper grids for SEM imaging could result in significant deformations of fibril topology. As a result, it is possible that a right-twist of reversed VCD fibrils may become distorted and therefore not apparent on SEM images. In order to show that reversed VCD fibrils do not have a right-handed twist on their surface we utilized one of the most preservative microscopic tools: cryo-SEM. (32) Cryo-SEM shows that reversed VCD lysozyme fibrils have flat-like topology without a right-handed twist. In fact applications of cryo-SEM for studies of insulin reversed VCD fibrils showed similar results, while at the same time this method confirmed the left-handed twist of normal VCD insulin fibrils (Supporting Information Figure S2).
Deep UV resonance Raman (DUVRR) spectroscopy has proven to be an efficient technique for characterizing protein structural rearrangements at all stages of fibrillation. (26, 33-37) In particular, DUVRR spectroscopy, together with hydrogen–deuterium exchange, has been found to be a powerful method for the determination of fibril cross-β-core structure. (38-40) Previously, using DUVRR spectroscopy we found that both normal and reversed insulin fibrils have the same spectrum and hence the same cross-β-core structure, while they have different environments for tyrosine (Tyr) amino acid residues. (23) In the present study we used DUVRR spectroscopy to demonstrate the same similarity of cross-β-sheet structures of normal and reversed VCD lysozyme fibrils with small differences for the aromatic side-chains between normal and reversed fibrils (Supporting Information Figure S3).

Apo-α-lactalbumin Aggregation

Apo-α-lactalbumin aggregation results in the formation of only reversed VCD fibrils at 37 °C. The protein α-lactalbumin is a small (∼14 kDa) metal binding protein present in the whey milk of most mammal species as a regulatory subunit of lactose synthase. (41) α-Lactalbumin consists of 123 amino acid residues arranged into two domains, designated α and β. The two domains are divided by a cleft, where a calcium ion is located. Reduction of two of four disulfide bonds in α-lactalbumin results in its adopting a molten globule conformation. (42) The molten globule state of α-lactalbumin is a well-studied structure that has native-like secondary structure with an absence of specific tertiary packing interactions of amino acid side chains. (43, 44)
Apo-α-lactalbumin is of particular interest since it is homologous to lysozyme, albeit with different aggregating and denaturing properties. (41) Aggregates of apo-α-lactalbumin form long unbranched fibrils under low pH and high ionic strength (Supporting Information Figure S4). (45) Previously the secondary structure of apo-α-lactalbumin fibrils has been extensively characterized in our group. (46, 47) In the current study we investigate the effect of pH on the formation of different VCD chiral polymorphs. Apo-α-lactalbumin (5 mg/mL) was incubated at different values of pH in the presence of 150 mM NaCl at 37 °C for 3 days. After fibril formation was terminated by centrifugation and temperature reduction, the VCD and IR spectra of the sample were measured. We found that fibrils grown at different pH values show reversed VCD, with a positive peak near 1624 cm–1 and a negative peak near 1639 cm–1 (Figure 3).

Figure 3

Figure 3. VCD (top) and IR (bottom) spectra of apo-α-lactalbumin fibrils grown at pH 1.5 (blue), 2.5 (green), 3.0 (black), and 4.0 (red) for 3 days at 37 °C.

As depicted, apo-α-lactalbumin aggregation at this concentration over the pH range from 1.5 to 4.0 at 37 °C results in an excess of only one chiral polymorph that has reversed VCD supramolecular chirality. Fibrils that were grown at pH (2.5) have the highest intensity of a peak at 1617 cm–1. Fibrils that were grown at pH 1.5 have relatively smaller intensity at 1617 cm–1, while the intensity of a negative peak at 1666 cm–1 is almost the same as for pH 2.5 fibrils. Fibrils that were grown at pH 3.0 have smaller intensity for all VCD bands relative to pH 1.5 and 2.5 fibrils centered at 1624 cm–1. Finally, fibrils grown at pH 4.0 have the smallest VCD intensity, and the peak previously observed at 1617 cm–1 for pH 1.5 and 2.5 is shifted to 1612 cm–1.
AFM was used to image fibrils of apo-α-lactalbumin that were deposited onto a freshly cleaved mica surface. The AFM images revealed both tape-like and left-twisted fibrils at all pH values. Tape-like fibrils had ∼26 nm width and ∼5 nm height, while left-twisted fibrils had the same width but were over twice as high (∼12 nm). Examples are shown in Figure 4.

Figure 4

Figure 4. Fluid-cell AFM images of left-twisted (a) and tape-like (b) fibrils of apo-α-lactalbumin grown for 3 days at 37 °C.

The amount of left-twisted fibrils decreased with an increase of aggregation pH (Supporting Information Figure S5). Specifically, they were abundant in a fibril solution that was grown at pH 1.5, while less frequently observed at pH 2.5. Finally, in the fibril solutions grown at pH 3.0 and 4.0 left-twisted fibrils were extremely rare (Supporting Information Figure S5). At the same time, the tape-like morphology was commonly observed for fibrils grown at all pH values.

HET-s (218–289) Peptide Fragment

HET-s (218–289) peptide fragment of prion protein forms opposite chiral polymorphs at different pH values. HET-s is a prion protein of the fungus Podospora anserina. It was previously shown that at low pH its C-terminal fragment (HET-s 218–289) slowly aggregates forming amyloid-like fibrils. (48) Several independent studies have shown that (HET-s 218–289) aggregation at pH 2.0 leads to a formation of thick left-twisted cables composed of 3–6 filaments. (48-50) At the same time, its aggregation at pH above 3.0 causes formation of thin fibrils without a noticeable twist. (48) Mizuno et al. proposed that these thin fibrils ought to have a left-handed twist, while no repeatable twist on the cryo-EM provided pictures was evident. (49) These thin fibrils were proposed to form a β solenoid (β-roll) with a triangular hydrophobic core. (51) It is also of interest to note that these two (HET-s 218–289) fibril polymorphs have different infectivity: fibrils at pH 2.0 showed very little if any infectivity, while fibrils formed at pH above 3.0 were found to be highly infectious. (48, 52, 53) On the basis of electronic circular dichroism (ECD) and IR spectroscopy, thick left-twisted cables and thin fibrils were found to have different secondary structure. (48) It was also shown that these two polymorphs have different assembly kinetics, resistance to denaturants, and intrinsic fluorescence. (48)
In our study we investigated supramolecular chirality of HET-s (218–289) prion fibrils grown at pH 2.0, 3.3, and 3.9 (Figure 6). It appears that pH 2.0 fibrils, which have a left-handed twist (Figure 6), exhibited very intense normal VCD. Thin fibrils grown at pH 3.3 and 3.9 (Figure 5) showed VCD spectra of the opposite sign with 1–2 orders of magnitude lower intensity. The normal sign patterns for pH 2.0 fibrils are 1557 (+), 1578 (+), 1614 (−), 1640 (+), and 1666 (+) cm–1, while the reversed sign pattern for pH 3.3 is 1560 (−), 1611 (+), 1636 (−) cm–1. HET-s (218–289) prion fibrils grown at pH 3.9 exhibit the same reversed sign pattern but have some differing VCD band frequencies: 1557 (+), 1614 (+), and 1660 (−) cm–1.

Figure 5

Figure 5. VCD (a) and IR (b) spectra of HET-s (218–289) fibrils grown at pH 2.0 (blue), 3.3 (green), and 3.9 (black) for 2 months at room temperature. For better visualization of band positions and intensities the insert shows VCD spectra of only pH 3.3 (green) and pH 3.9 (black) fibrils.

Figure 6

Figure 6. AFM images of HET-s (218–289) prion fibrils grown in pH 2.0 (a) and 3.9 (b).

The IR spectra of all studied samples exhibit a peak around 1620 cm–1, indicating a predominance of β-sheet structure (Figure 5b). (29) It was found that that the position of this peak is slightly shifted in the spectrum of fibrils grown at pH 2.0 (1624 cm–1) compared to the corresponding IR band for fibrils grown at pH 3.3 and 3.9 fibrils (1620 cm–1). Moreover, the IR at pH 2.0 has higher intensity for peaks at 1725 and 1671 cm–1compared to those of fibrils grown at pH 3.3 and 3.9. These differences indicate structural deviations of normal and reversed VCD chiral polymorphs of HET-s fibrils. For more detailed structural characterization of their secondary structure we applied DUVRR (Supporting Information Figure S6). The positions of amide I, II bands and Cα-H band are nearly identical in the spectra of both chiral polymorphs, which indicates a high level of similarity of secondary structure for all three fibril pH values. At the same time, we found that HET-s fibrils that were grown at pH 3.9 have substantially higher amount of unordered structure (a peak ∼1268 cm–1) compared to the pH 2.0 fibrils. (54)
AFM was utilized to reveal morphological organization of the analyzed HET-s (218–289) prion fibrils. We found that fibrils grown at pH 2.0 have a well-defined left-handed twist, 40 nm in width and around 3 nm in height (Figure 7). At the same time, fibrils that were grown at pH 3.9 (reversed VCD) exhibited no twist on their surface. They had a shape of flat tapes that have 25 nm in width and ∼2 nm in height.

Figure 7

Figure 7. VCD (top) and IR (bottom) spectra of TTR (105–115) fibrils grown at pH 1.0 (blue), 1.5 (green), 2.0 (black), 2.5 (red), and 3.0 (violet) for 2 days at 37 °C followed by 14 days at room temperature.

TRR (105–115) Peptide Fragment

Opposite chiral polymorphs are observed for fibrils formed from a small peptide of human transthyretin. TTR (105–115) is a peptide fragment of transthyretin, a 55 kDa protein involved in the transport pathway of thyroxine and retinol in plasma. (55) Although this peptide is itself not implicated in any human disease, fibrillization of the full-length protein has been linked to familial amyloid polyneuropathy (FAP) and senile systemic amyloidosis (SSA). (56) Transthyretin has a β-sheet rich structure and can form amyloid-like aggregates in vivo. Previously, it was demonstrated that TTR (105–115) is able to aggregate in vitro, forming amyloid-like fibrils. (57) We grew TTR (105–115) fibrils as described previously, (57) at different pH values for 2 days at 37 °C followed by 14 days at room temperature.
As shown in Figure 7, the IR spectra of TTR (105–115) feature a strong band at 1623 cm–1 that is characteristic of β-sheet structure. As with insulin, lysozyme, and HET-s prion fibrils described above, the VCD sign of TTR (105–115) reverses as a function of small changes in pH during protein aggregation. TTR (105–115) fibrils formed at pH 2.0 and above show strong reversed VCD, and the intensity of the positive 1624 cm–1 VCD band increases within increase of aggregation pH. Similar to HET-s fibrils, and opposite insulin and lysozyme, higher pH favors formation of the reversed VCD for TTR (105–115) fibrils. The magnitude of reversed VCD intensities observed for these fibrils is nearly the same as those previously observed for reversed VCD insulin fibrils (formed at low pH). By contrast, TTR (105–115) fibrils grown at pH values 1.5 and 1.0 show normal VCD with their VCD intensities in the range 2–6 times smaller than the VCD intensities of reversed TTR (105–115) fibrils.
AFM was applied to characterize morphologies of normal and reversed VCD TTR (105–115) fibrils (Figure 8). We found that normal and reversed VCD AFM images of TTR (105–115) display different morphologies. TTR (105–115) fibrils that were grown at pH 1.5 are long and have cylindrical shapes. Together with long rod-like fibrils we observed large amounts of small spherical species, which may be fibril precursors (Figure 8a). TTR (105–115) fibrils grown at higher pH (pH 2.5) are significantly shorter than fibrils grown at pH 1.5. Their length almost never exceeds 100 nm. In addition to the diverse morphologies fibrils with normal and reversed VCD, TTR (105–115) fibril polymorphs have different heights: normal (pH 1.5) VCD fibrils are around 5 nm, while reversed VCD (pH 2.0) fibrils are around 9 nm.

Figure 8

Figure 8. AFM images of TTR (105–115) fibrils grown at (a) pH 1.5 and (b) pH 2.5. Scale bar is 100 nm.

More detailed surface analysis of TTR (105–115) fibrils grown at pH 2.5 (Figure 8b) indicates that some of them are composed of several side-by-side associated proto-fibrils. We did not observe any twist either on the surface of this chiral polymorph or on the surface of fibrils grown at pH 1.5. Flat-like topology of TTR (105–115) fibrils grown at pH 2.0, 37 °C (here reversed VCD) was previously confirmed by Jaroniec et al. (58) It was shown that these fibrils are composed of several side-by-side associated proto-fibrils. However, no measurement of the VCD of these fibrils was previously reported.
The application of DUVRR spectroscopy allowed us to elucidate the secondary structure organization of both normal and reversed VCD of TTR (105–115) fibrils (Supporting Information Figure S7). Both chiral polymorphs of TTR (105–115) fibrils have narrow and intense amide I, II, and III bands, which indicate that they share the same cross-β core structure. We found that the intensity of the Tyr band is also identical in both normal and reversed VCD TTR (105–115) fibrils, indicating high similarities in Tyr local environment of both polymorphs.

Discussion

Click to copy section linkSection link copied!

With the results presented here, VCD intensity, enhanced by more than 1 order of magnitude over isolated protein levels, has been observed for three additional amyloid fibrils, namely apo-α-lactalbumin, the HET-s (218–289) prion-forming domain, and TTR (105–115) peptide fragment from transthyretin. In a separate publication, similarly enhanced VCD has also been reported for a number of polyglutamine (polyQ) fibrils from Q15 to Q45. (59)
Also with this paper, control of the sense of amyloid fibril chirality, normal versus reversed, by incubation under relatively small variations in pH, previously reported only for insulin, (23) has been extended to lysozyme as well as apo-α-lactalbumin, HET-s (218–289), and TTR (105–115). As with insulin, the sign pattern, defined above, for enhanced VCD intensity is (+ + – + +) for normal fibrils, and the nearly mirror-image relative intensity pattern with signs (− – + – −) for reversed fibrils reflects an underlying level of fibril chirality. Of these signed bands, the band near 1620 cm–1, corresponding to the principal IR marker band for fibril protein structure, is the most intense and is the primary marker band for VCD fibril chirality.
The principal focus of this paper is to correlate fibril supramolecular chirality, based on the sign pattern of enhanced VCD, to the two major classes of fibril morphology, either left-twisted or flat tape-like, as revealed by AFM or SEM imaging. The details of this correlation from results described in the previous section, as well as the earlier reported results for insulin, (23-25) are summarized in Table 1 for ease of comparison. For the proteins and peptide fragments reported here, each has a different sensitivity to pH although the sensitivity of lysozyme is similar to that of insulin: normal VCD is observed above approximately pH 2.2 and reversed VCD below that pH.
Table 1. Dependence of the Fibril Morphology and VCD on the Aggregation pH for Insulin, Lysozyme, apo-α-Lactalbumin, HET-s (218-289), and TTR (105-115) Fibrils
protein, incubation conditionspH regionmorphologyVCD sign patternΔA/A ∼1620 cm-1
insulin, 24 h at 70 °C1.3–2.1flat tape-likereversed0.15 × 10–4 to 0.18 × 10–4
 2.4–3.1left-twistednormal–1 x10–4 to –3.5 × 10–4
lysozyme, 3 days at 65 °C1.0–1.9flat tape-likereversed0.9 × 10–2 to 1.7 × 10–2
 2.3flat tape-like, left-twistednormal, reversed–2 × 10–4
 2.7left-twistednormal–8 × 10–3
apo-α-lactalbumin, 3 days at 37 °C1.5–2.5left-twisted > flat tape-likereversed4.2 × 10–4 to 5.1 × 10–4
 3.0flat tape-likereversed3.3 × 10–4
 4.0flat tape-likereversed0.25 × 10–4
HET-s (218–298), 2 months at room temp2.0left-twistednormal–1.2 × 10–2
 3.3–3.9flat tape-likereversed2.5 × 10–4 to 4.7 × 10–4
TTR (105–115), 2 days at 37 °C followed by 14 days at room temp1.0–1.5cylindrical, presumably left-twistednormal–0.5 × 10–4 to −1 × 10–4
 2.0–3.0flat tape-likereversed2.5 × 10–4 to 7 × 10–4
Apo-α-lactalbumin also shows reversed VCD at low pH. For this protein though, no point of VCD sign reversal is reached between pH 1.5 and 4.0. If it were to reverse sign pattern, it is predicted to do so only below pH 1.5 when the population of left-twisted fibrils becomes sufficiently dominant relative to flat tape-like, as reasoned further in the next paragraph. We have found that, at pH 1.5, the relative populations of reversed tape-like fibrils and normal left-twisted fibrils marginally favor the left-twisted fibrils (see Table 1 and Supporting Information Figure S5); however, the VCD spectrum indicates in Figure 3 that reversed tape-like fibrils are more influential, perhaps because reversed fibrils in this region have intrinsically higher VCD intensity. At pH 2.5, the reversed VCD increases, as the population of normal left-twisted fibrils decreases, in agreement with the idea that these two morphologies have opposite VCD and reduction of left-twisted fibrils permits an overall increase in the observed, net-reversed VCD spectrum. As the pH is increased to 3.0 and then to 4.0, the population of left-twisted fibrils becomes close to zero, but unexpectedly the observed reversed VCD decreases dramatically from pH 2.5 to 3.0 and then to a relative small value for pH 4.0. This reduction must solely be due to a reduction in the long-range chirality of the flat tape-like fibrils. From Supporting Information Figure S5 the observed height distribution of the flat tape-like fibrils narrows considerably to near 6 nm with increasing pH. One possible explanation for these observations is that as the pH increases beyond pH 2.5, the stability of the aggregation of right-handed (reversed) filaments that form multifilament tape-like fibrils decreases until at pH 4 only the lowest level of fibril structure remains, possibly only individual filaments having no lateral associations of filaments. Beyond pH 4, not even the simplest fibril filament structures are stable, and fibrillation of any kind no longer occurs. Thus, although the pH dependence of apo-α-lactalbumin differs substantially from that of insulin and lysozyme, our understanding of the VCD and AFM imaging for this protein still supports the evidence that the sign pattern for VCD correlates without exception to the morphology of the observed microscopic images of the fibrils grown at various pH values.
The two peptide fragments, HET-s (218–289) and TTR (105–115), show the opposite VCD sign behavior compared with insulin and lysozyme, with normal fibrils appearing at low pH and reversed fibrils at high pH, although in these two cases the level of VCD enhancement differs dramatically. For the HET-s (218–289) peptide, the low-pH normal VCD is extremely large with high-pH reversed VCD significantly smaller, whereas for the TTR (105–115) peptide the low-pH normal VCD is small and the high-pH reversed VCD is much larger.
One possible influence beyond the value of pH was explored by introducing differing amounts of sodium chloride and thereby changing the ionic strength at a given pH value. Experiments to date have shown no such influence of ionic strength (Supporting Information Figure S8). Another variable partially explored is the effect of incubation temperature, duration of incubation, and time after incubation. Here variations in VCD intensity have been observed from which one concludes, as is well-known from many previous studies, that fibril formation, development, and stability can depend significantly on these variables.
While studying the dependence of lysozyme fibril supramolecular chirality on incubation conditions we found that prolonged fibril exposure at the elevated temperature results in a decrease of VCD intensity. As previously demonstrated, fibril formation and development is associated with the continuous increase in the VCD intensity of the analyzed solution. (22) Since fibril fragmentation is the opposite process, it should be associated with a decrease in VCD intensity. (22) Therefore, one would expect that the observed decrease of fibril VCD intensity for lysozyme is indicative of fibril fragmentation during extended development. In fact, this propensity of fibrils has been extensively studied and proposed to be an intrinsic mechanism of fibril self-propagation, since each individual fibril fragment may act as a seed and give a birth to a new full-length fibril. (60, 61)
In the Results section, we noted on several occasions that the sign of the major VCD peak appears to shift from the region of 1620 cm–1 to near 1610 cm–1. However, there is no corresponding shift in the peak maxima of the corresponding IR bands near 1620 cm–1. A highly likely explanation for the large frequency shift away from the vicinity of 1620 cm–1 is that two opposite-signed VCD bands, with peak maxima only a few wavenumbers apart, interfere and give rise to a couplet of opposite signed VCD bands reduced in intensity but separated by a frequency difference related with the widths of the individual opposite signed VCD bands. Such interference and splitting for peak maxima do not occur for the parent IR bands since their intensity contributions reinforce rather than partially cancel.
Combining these VCD observations with correlated AFM images as summarized in Table 1 reveals a correlation, without exception, of the normal VCD sign pattern with fibrils displaying a predominantly rounded left-twisted helical morphology and the reversed VCD sign pattern with fibrils having a flat tape-like morphology. For the flat tape-like fibrils there is no indication of fibril chirality in their AFM or SEM images. In the case of insulin, this correlation led us to propose that the enhanced, opposite-signed, mirror-image-like intensity pattern of VCD must have its origins at a deeper level of fibril structure than that visible for fibril morphology using AFM or SEM imaging. (24) Further, we proposed that opposite VCD sign patterns for normal and reversed fibrils originated at the level of individual fibril filaments, the simplest level of fibril cross-β core structure, with filament axial helical twists of opposite sense, left-handed for normal fibrils and right-handed for reversed fibrils. (24) It follows from this proposition that left-twisted filaments form braids of multiple-filament left-twisted fibrils with observable left-twisted morphology, while right-twisted fibrils do not braid and instead adopt a flat tape-like morphology consisting of parallel side-by-side filaments. To our knowledge, imaging the chirality of individual filaments has not been conclusively observed, and consequently, (8, 62) VCD to date is the only known structure probe of fibril chirality at the level of individual filaments. (24) This point is reinforced by the fact that VCD can follow fibril formation as intensity enhancement from the earliest stages of filament formation, (22, 24) and that the enhanced VCD intensity grows without a substantial change in the relative intensity pattern as filaments first form, then associate and develop into mature fibrils. Further in the case of insulin, on the basis of the observation that reversed fibrils spontaneously convert to normal fibrils upon raising the pH into the normal fibril pH range whereas normal fibrils do not convert to reversed fibrils when the pH is correspondingly reduced to the reversed fibril pH range, we have concluded that normal left-twisted mature fibrils are more thermodynamically stable, at least for insulin, than flat tape-like fibrils. (25) This correlates with the idea that left-twisted filament-braided mature fibrils are in deeper thermodynamic sinks from which reversal or decomposition requires extremes of temperature or pH.
We have also considered whether there is any correlation between the pH dependence of filament chirality and pI values for the protein/peptide and found that there appears to be little or no correlation between protein pI and pH dependence of filament chirality. For example, the pI for insulin is 5.30–5.35, while for lysozyme the pI is 10.6–10.9. Nevertheless, both of these proteins exhibit nearly the same pH dependent fibril chirality. At the same time, the pI of HET-s (218–289) is 9.19, while it exhibits the opposite pH chirality dependence of lysozyme (pI 10.6–10.9). For apo-α-lactalbumin the pI (4.2–4.5) (41) is very close to the pI of insulin (5.30–5.35); however, we observed formation of only one chiral polymorph for apo-α-lactalbumin. Finally, HET-s (218–289) and TTR (105–115) exhibit similar pH dependence of fibril chirality (normal at low pH and reversed at high pH). Nevertheless, their pIs are substantially different: 9.19 for HET-s (218–289) and 6.09 for TTR (105–115). The only correlation might be that the substantial difference in pI’s of apo-α-lactalbumin (4.2–4.5) and lysozyme (pI 10.6–10.9) might be related to the difference in pH chirality dependence for these two isostructural proteins in their native states. The pI values provided here were determined as described in Supporting Information.
Although the focus here is to relate the sign pattern of the enhanced VCD to the major classes of fibril morphology, inspection of the IR absorption spectra for fibrils described in Figures 1, 3, 5, and 7 reveals variations in a band in the 1650–1670 region that also shows intensity differences that correlate with VCD sign and fibril morphology. Not as dramatic as the VCD sign pattern, there is likely interesting information about the differences between left-twisted and flat tape-like fibrils associated with these IR bands. In the Results section for lysozyme we attributed this band to nonordered or loop structure. An open question to be pursued in future studies is whether this band is associated with a fully formed fibril filament (cross-β-core) or with partially unfolded proteins yet to be incorporated into the filament or fibril structure. At least for lysozyme and insulin (not shown here), this band may be associated with parts of the protein structure not in the cross-β-core for which there would be more residues than for the shorter peptides from HET-s and TTR.
Finally, examination of the structural organization of the opposite chiral polymorphs using DUVRR and IR spectroscopy shows that insulin, lysozyme, and TTR (105–115) fibril polymorphs have the same secondary structure. At the same time, we have found that normal and reversed VCD chiral polymorphs of HET-s (218–289) fibrils have small differences secondary structure distributions with the same cross-β-core structure.

Theoretical Considerations

Click to copy section linkSection link copied!

Although the primary findings of this paper are drawn from new experimental results, namely VCD spectra and AFM/SEM images as a function of incubation pH for four protein molecules beyond our previously published findings for insulin, we offer in this section our views of the theoretical, molecular-level implications for what the experimental evidence suggests.

Filament Chirality

The theoretical model of Schweitzer-Stenner (63) is the first and simplest computational model of enhanced VCD in fibrils, first observed by Ma et al. (22) The model is based on exciton coupling among amide I transition dipoles arrayed as dual, stacked β-sheet ribbons corresponding to the simplest representation of the structure of a single cross-beta core filament. The strands in this model, only two peptide units long, run perpendicular to the filament axis direction. In order to generate enhanced VCD, a twist of 2° was introduced between the strands yielding a long-range gradual helical twist to the filament structure with a one full-turn distance of 180 strands. It was found that such a structure yields enhanced VCD that corresponds to what is referred to as normal VCD (negative VCD near 1620 cm–1 with positive VCD to higher wavenumber frequencies) for a left-hand helical fibril twist. A corresponding 2° intrastrand helical twist in the opposite direction, corresponding to a right-hand helical filament, reversed the sign of the enhanced VCD couplet and corresponds to our reversed VCD. Filament chirality is therefore a very delicate, subtle level of protein chirality that is apparently sensitive to incubation pH. Most likely, the sensitivity of amino-acid side chains to the aqueous solvent is responsible for this pH sensitivity, and apparently, differing arrays of constituent side-chains, exposed or not to the solvent, results in different pH sensitivity (high versus low) for the sense of filament chirality observed. This is a long-range fibril property that likely cannot be predicted, even qualitatively, without a realistic model of protein side chain influence on the sense of helical chirality as a function of pH. As far as we are aware, the chirality of individual fibril filaments lies below the sensitivity of AFM or SEM imaging, but can be observed with VCD at the initial and subsequent stages of fibril formation. (22-25)

Fibril Chirality and Morphology

It is known from AFM and SEM images that fibril filaments form higher levels of structure subsequent to the formation of individual filaments. It has been demonstrated, for example by kinetic studies, (22) that the degree of enhancement of VCD is sensitive to the degree of filament association as fibrils mature and develop. This is particularly true for the left-twisted morphologies composed of multifilament chiral braids of left-helical filaments and to a lesser degree for the flat morphologies of side-by-side associations of right-helical filaments. An important unanswered question is why only left-helical filaments form braids corresponding to the left-twisted fibril morphology as illustrated diagrammatically in Figure 9. The answer most likely is that left- and right-helical filaments are not mirror-image structures as both consist of l-amino acid residues. A model calculation of this property, the appearance of left-twisted braids and nonappearance of right-twisted braids of helical filaments, again involves consideration of the structure and influence of amino acid side chains. The model of Schweitzer-Stenner applies only to the filament level of structure and does not include any side chain chirality (l- or d-amino acid residues) or filament–filament interactions or braiding. Answering the question of why only left-twisted fibril images and VCD are observed is two levels beyond the Schweitzer-Stenner (S-S) model of enhanced VCD. One first needs a more realistic model of cross-β-core filament structure that includes side chain detail, and second, one needs to extend such a model to a new, higher level of fibril chirality, namely the chiral braiding of multiple-filament fibril structure.

Figure 9

Figure 9. Diagram illustrating the progression from folded protein to individual straight filament with chirality below the senstivity of AFM/SEM and on to mature multifilament fibrils with right helical filaments forming flat tape-like fibrils of straight filaments and left helical filaments forming, possibly more stable, left twisted braids of filaments. The pH dependence may vary between proteins/peptides but not the VCD intensity patterns (normal left helical filaments versus reversed for right helical filaments).

A step in this direction has just been published by Welch, Kubelka, and Keiderling (WKK). (64, 65) They employ modeling at the level of a full DFT calculation with transfer of parameters from smaller peptides to build large β-sheet structures. Their model is quite different in dimension from the (S-S) model although both use stacked β-sheets to simulate the cross-β-core structure. The WKK model involves strands that are 10 residues instead of 2 residues wide, but the fibril axis is only 5 strands long rather than in the 100-strand range. To induce enhanced VCD, they introduce a twist along the strand direction, not the fibril axis direction, of 15° between residues. They also explore a rotation of the stacked sheets relative to each of 45°, again a chiral departure from an initial achiral cross-β core structure. These two degrees of chiral freedom may be important as filaments aggregate and braid about a common axis. The point needs to be explored as the models move beyond individual filament models and on to multifilament simulations of more mature fibrils. Nevertheless, it seems reasonable that chirality along the filament axis, as emphasized in this paper (see Figure 9), as opposed to the more local strand or intersheet twist chirality, (64, 65) is the form of filament chirality that can be extended most easily to the supramolecular level of filament structure and hence to VCD enhanced by up to 2 orders of magnitude relative to the isolated-protein VCD intensity level.
At this stage, even with the recent work of WKK, there are no structural models of interfilament association leading to the formation of different fibril morphologies. It is our view that the realization of a model, even at the course grain level, that is capable of rationalizing the correlation of left-helical filaments to left-twisted fibril morphology and right-helical filaments to flat fibril morphology, is beyond the reach of near-term possibilities and must await further advances in our understanding of the unusual sensitivity of VCD to filament and mature fibril chirality as well as the many chiral degrees of freedom that may influence fibril morphology.
Two further observations relevant to this discussion have been established previously for insulin and remain to be confirmed more systematically for the new fibril results presented here. As fibrils grow by adding filaments and becoming thicker, the VCD grows from initially observed levels, whereas the IR intensity does not grow in overall magnitude. (22-25) This is more dramatically true for the braided left-twisted morphology where an additional order of magnitude of VCD may be observed compared to the initial enhanced VCD of newly formed filaments. This strongly implies a second level of chirality beyond the filament level that is IR intensity neutral. Second, the left twisted morphology is more stable than the flat tape-like morphology. (25) Thus, the interfilament interactions of the left-twisted braided fibril consisting of left-helical filaments are stronger than the corresponding side-by-side interactions of the flat tape-like fibrils composed of right-helical filaments. A successful model of fibril morphology and associated VCD intensity should reflect this difference in thermodynamic stability.

Conclusions

Click to copy section linkSection link copied!

The results of the present study, and the absence of any observable chirality by AFM for flat tape-like fibrils, extends, beyond the case of insulin, the correlation of the sign of VCD intensity pattern with the two major classes of amyloid fibril morphology, round left-twisted and flat tape-like. Also extended by this study (to fibrils of four new protein or peptide fragments) is the hypothesis that the near mirror-like opposite-signed VCD patterns associated with these two morphologies arise from the opposite sense of helical twist of individual fibril filaments that comprise observed multifilament, more-fully developed fibrils. Further, for all five analyzed amyloid fibrils documented in Table 1, filament chirality appears to lie below the level of direct detection of AFM or SEM imaging. Finally, there is wide variability in the pH dependence of filament chirality, being one sense (reversed, right-handed at lower pH and normal, left-handed at higher pH) for the proteins insulin, lysozyme, and apo-α-lactalbumin, and the opposite sense (normal, left-handed at lower pH and reversed right-handed at higher pH) for the peptide fragments HET-s (218–289) from prion protein, and TTR (105–115) from transthyretin. We have investigated whether there is any correlation between pH dependence of filament chirality and the pI of the protein/peptide and found no direct correlation. Thus, we have shown extensive new evidence that supports an affirmative answer to the question posed in the title of this paper. Namely, yes, the chirality of individual amyloid fibril filaments does indeed appear to be the underlying cause of the major morphological differences (round twisted versus flat tape-like) in all amyloid fibrils explored to date by VCD. Nevertheless, the protein/peptide fibrils sampled for morphology and VCD is so far limited to five, albeit somewhat diverse, cases, and there well could be surprises and exceptions in future studies. A final understanding of the correlations reported here must await sufficiently realistic and accurate modeling of filament and fibril chirality together with the calculation of the associated VCD spectra.

Supporting Information

Click to copy section linkSection link copied!

Detailed experimental procedure, materials, and methods. Figures S1–S8. This material is available free of charge via the Internet at http://pubs.acs.org.

Terms & Conditions

Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html.

Author Information

Click to copy section linkSection link copied!

  • Corresponding Author
    • Laurence A. Nafie - Department of Chemistry, Syracuse University, 1-014 Center for Science and Technology, Syracuse, New York 13244, United StatesBioTools, Inc., 17546 Bee Line Highway, Jupiter, Florida 33458, United States
  • Authors
    • Dmitry Kurouski - Department of Chemistry, University at Albany, State University of New York, 1400 Washington Avenue, Albany, New York 12222, United States
    • Xuefang Lu - BioTools, Inc., 17546 Bee Line Highway, Jupiter, Florida 33458, United States
    • Ludmila Popova - Department of Chemistry, University at Albany, State University of New York, 1400 Washington Avenue, Albany, New York 12222, United States
    • William Wan - Department of Biological Sciences and Center for Structural Biology, Vanderbilt University, Box 351634 Station B, Nashville, Tennessee 37235, United States
    • Maruda Shanmugasundaram - Department of Chemistry, University at Albany, State University of New York, 1400 Washington Avenue, Albany, New York 12222, United States
    • Gerald Stubbs - Department of Biological Sciences and Center for Structural Biology, Vanderbilt University, Box 351634 Station B, Nashville, Tennessee 37235, United States
    • Rina K. Dukor - BioTools, Inc., 17546 Bee Line Highway, Jupiter, Florida 33458, United States
    • Igor K. Lednev - Department of Chemistry, University at Albany, State University of New York, 1400 Washington Avenue, Albany, New York 12222, United States
  • Notes
    The authors declare no competing financial interest.

Acknowledgment

Click to copy section linkSection link copied!

We are grateful to Jonas Baltrusaitis from University of Iowa for performing cryo-SEM imaging and Dr. Alexander V. Zabula for valuable graphical assistance. This work was supported by National Institute on Aging, National Institute of Health, Grant R01AG033719 (I.K.L.); National Institutes of Health Grants AG002132 (G.S.) and F31-AG040947 (G.S.); and the National Science Foundation (SBIR phase II Grant IIP-0945484 to R.K.D., L.A.N., and X.L.).

References

Click to copy section linkSection link copied!

This article references 65 other publications.

  1. 1
    Dobson, C. M. Nature 2003, 426, 884 890
  2. 2
    Makarava, N.; Baskakov, I. V. J. Biol. Chem. 2008, 283, 15988 15996
  3. 3
    Goldsbury, C. S.; Wirtz, S.; Muller, S. A.; Sunderji, S.; Wicki, P.; Aebi, U.; Frey, P. J. Struct. Biol. 2000, 130, 217 231
  4. 4
    Dische, F. E.; Wernstedt, C.; Westermark, G. T.; Westermark, P.; Pepys, M. B.; Rennie, J. A.; Gilbey, S. G.; Watkins, P. J. Diabetologia 1988, 31, 158 161
  5. 5
    Chiti, F.; Dobson, C. M. Annu. Rev. Biochem. 2006, 75, 333 366
  6. 6
    Dobson, C. M. Trends Biochem. Sci. 1999, 24, 329 332
  7. 7
    Jansen, R.; Grudzielanek, S.; Dzwolak, W.; Winter, R. J. Mol. Biol. 2004, 338, 203 206
  8. 8
    Jimenez, J. L.; Nettleton, E. J.; Bouchard, M.; Robinson, C. V.; Dobson, C. M.; Saibil, H. R. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 9196 9201
  9. 9
    Bauer, H. H.; Aebi, U.; Haner, M.; Hermann, R.; Muller, M.; Merkle, H. P. J. Struct. Biol. 1995, 115, 1 15
  10. 10
    Goldsbury, C. S.; Cooper, G. J.; Goldie, K. N.; Muller, S. A.; Saafi, E. L.; Gruijters, W. T.; Misur, M. P.; Engel, A.; Aebi, U.; Kistler, J. J. Struct. Biol. 1997, 119, 17 27
  11. 11
    Cardoso, I.; Goldsbury, C. S.; Muller, S. A.; Olivieri, V.; Wirtz, S.; Damas, A. M.; Aebi, U.; Saraiva, M. J. J. Mol. Biol. 2002, 317, 683 695
  12. 12
    Anderson, M.; Bocharova, O. V.; Makarava, N.; Breydo, L.; Salnikov, V. V.; Baskakov, I. V. J. Mol. Biol. 2006, 358, 580 596
  13. 13
    Paravastu, A. K.; Leapman, R. D.; Yau, W. M.; Tycko, R. Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 18349 18354
  14. 14
    Wischik, C. M.; Novak, M.; Thogersen, H. C.; Edwards, P. C.; Runswick, M. J.; Jakes, R.; Walker, J. E.; Milstein, C.; Roth, M.; Klug, A. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 4506 4510
  15. 15
    Luhrs, T.; Ritter, C.; Adrian, M.; Riek-Loher, D.; Bohrmann, B.; Dobeli, H.; Schubert, D.; Riek, R. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 17342 17347
  16. 16
    Adamcik, J.; Mezzenga, R. Soft Matter 2011, 7, 5437 5443
  17. 17
    Petkova, A. T.; Leapman, R. D.; Guo, Z.; Yau, W.-M.; Mattson, M. P.; Tycko, R. Science 2005, 307, 262 265
  18. 18
    Dzwolak, W.; Pecul, M. FEBS Lett. 2005, 579, 6601 6603
  19. 19
    Dzwolak, W.; Loksztejn, A.; Galinska-Rakoczy, A.; Adachi, R.; Goto, Y.; Rupnicki, L. J. Am. Chem. Soc. 2007, 129, 7517 7522
  20. 20
    Loksztejn, A.; Dzwolak, W. J. Mol. Biol. 2008, 379, 9 16
  21. 21
    Nafie, L. A. Vibrational Optical Activity: Principles and Applications; Wiley: Chichester, U.K., 2011.
  22. 22
    Ma, S.; Cao, X.; Mak, M.; Sadik, A.; Walkner, C.; Freedman, T. B.; Lednev, I. K.; Dukor, R. K.; Nafie, L. A. J. Am. Chem. Soc. 2007, 129, 12364 12365
  23. 23
    Kurouski, D.; Lombardi, R. A.; Dukor, R. K.; Lednev, I. K.; Nafie, L. A. Chem. Commun. 2010, 46, 7154 7156
  24. 24
    Kurouski, D.; Dukor, R.; Lu, X.; Nafie, L. A.; Lednev, I. K. Biophys. J. 2012, 103, 522 531
  25. 25
    Kurouski, D.; Dukor, R. K.; Lu, X.; Nafie, L. A.; Lednev, I. K. Chem. Commun. 2012, 48, 2837 2839
  26. 26
    Shashilov, V.; Xu, M.; Ermolenkov, V. V.; Fredriksen, L.; Lednev, I. K. J. Am. Chem. Soc. 2007, 129, 6972 6973
  27. 27
    Xu, M.; Ermolenkov, V. V.; He, W.; Uversky, V. N.; Fredriksen, L.; Lednev, I. K. Biopolymers 2005, 79, 58 61
  28. 28
    Xu, M.; Ermolenkov, V. V.; Uversky, V. N.; Lednev, I. K. J. Biophotonics 2008, 1, 215 229
  29. 29
    Jackson, M.; Mantsch, H. H. Crit. Rev. Biochem. Mol. Biol. 1995, 30, 95 120
  30. 30
    Rubin, N.; Perugia, E.; Goldschmidt, M.; Fridkin, M.; Addadi, L. J. Am. Chem. Soc. 2008, 130, 4602 4603
  31. 31
    Lara, C.; Adamcik, J.; Jordens, S.; Mezzenga, R. Biomacromolecules 2011, 12, 1868 1875
  32. 32
    Rubin, N.; Perugia, E.; Wolf, S. G.; Klein, E.; Fridkin, M.; Addadi, L. J. Am. Chem. Soc. 2010, 132, 4242 4248
  33. 33
    Lednev, I. K. In Protein Structures, Methods in Protein Structures and Stability Analysis; Uversky, V. N.; Permyakov, E. A., Eds.; Nova Sci.: New York, 2007; pp 1 26.
  34. 34
    Arnaud, C. Chem. Eng. News 2009, 87, 10 14
  35. 35
    Xu, M.; Shashilov, V.; Lednev, I. K. J. Am. Chem. Soc. 2007, 129, 11002 11003
  36. 36
    Shashilov, V. A.; Lednev, I. K. J. Am. Chem. Soc. 2008, 130, 309 317
  37. 37
    Sikirzhytski, V.; Topilina, N. I.; Higashiya, S.; Welch, J. T.; Lednev, I. K. J. Am. Chem. Soc. 2008, 130, 5852 5853
  38. 38
    Olapedo, S. A..; Xiong, K.; Hong, Z.; Asher, S. A.; Handen, J.; Lednev, I. K. Chem. Rev. 2012, 112, 2604 2628
  39. 39
    Shashilov, V. A.; Sikirzhytski, V.; Popova, L. A.; Lednev, I. K. Methods 2010, 52, 23 37
  40. 40
    Shashilov, V. A.; Lednev, I. K. Chem. Rev. 2010, 110, 5692 5713
  41. 41
    Permyakov, E. A. Alpha-lactalbumin; Nova Sci., New York, 2005.
  42. 42
    Redfield, C.; Schulman, B. A.; Milhollen, M. A.; Kim, P. S.; Dobson, C. M. Nat. Struct. Biol. 1999, 6, 948 952
  43. 43
    Kataoka, M.; Kuwajima, K.; Tokunaga, F.; Goto, Y. Protein Sci. 1997, 6, 422 430
  44. 44
    Kuwajima, K. FASEB J. 1996, 10, 102 109
  45. 45
    Goers, J.; Permyakov, S. E.; Permyakov, E. A.; Uversky, V. N.; Fink, A. L. Biochemistry 2002, 41, 12546 12551
  46. 46
    Kurouski, D.; Lauro, W.; Lednev, I. K. Chem. Commun. 2010, 46, 4249 4251
  47. 47
    Kurouski, D.; Lednev, I. K. Int. J. Biomed. Nanosci. Nanotechnol. 2011, 2, 167 176
  48. 48
    Sabate, R.; Baxa, U.; Benkemoun, L.; Sanchez de Groot, N.; Coulary-Salin, B.; Maddelein, M. L.; Malato, L.; Ventura, S.; Steven, A. C.; Saupe, S. J. J. Mol. Biol. 2007, 370, 768 783
  49. 49
    Mizuno, N.; Baxa, U.; Steven, A. C. Proc. Natl. Acad. Sci. U.S.A. 2011, 108, 3252 3257
  50. 50
    Sen, A.; Baxa, U.; Simon, M. N.; Wall, J. S.; Sabate, R.; Saupe, S. J.; Steven, A. C. J. Biol. Chem. 2007, 282, 5545 5550
  51. 51
    Wasmer, C.; Lange, A.; Van Melckebeke, H.; Siemer, A. B.; Riek, R.; Meier, B. H. Science 2008, 319, 1523 1526
    Kajava, A. V.; Seven, A. C. Adv. Protein Sci. 2006, 73, 55 96
  52. 52
    Benkemoun, L.; Sabate, R.; Malato, L.; Dos Reis, S.; Dalstra, H.; Saupe, S. J.; Maddelein, M. L. Methods 2006, 39, 61 67
  53. 53
    Nazabal, A.; Maddelein, M. L.; Bonneu, M.; Saupe, S. J.; Schmitter, J. M. J. Biol. Chem. 2005, 280, 13220 13228
  54. 54
    Lednev, I. K.; Ermolenkov, V. V.; Higashiya, S.; Popova, L. A.; Topilina, N. I.; Welch, J. T. Biophys. J. 2006, 91, 3805 3818
  55. 55
    Damas, A. M.; Saraiva, M. J. J. Struct. Biol. 2000, 130, 290 299
  56. 56
    Gustavsson, A.; Engstrom, U.; Westermark, P. Biochem. Biophys. Res. Commun. 1991, 175, 1159 1164
  57. 57
    Jaroniec, C. P.; MacPhee, C. E.; Bajaj, V. S.; McMahon, M. T.; Dobson, C. M.; Griffin, R. G. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 711 716
  58. 58
    Jaroniec, C. P.; MacPhee, C. E.; Astrof, N. S.; Dobson, C. M.; Griffin, R. G. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 16748 16753
  59. 59
    Kurouski, D.; Kar, K.; Wetzel, R.; Dukor, R. K.; Lednev, I. K.; Nafie, L. A. FEBS Lett. 2013, 587, 1638 1643
  60. 60
    Smith, J. F.; Knowles, T. P.; Dobson, C. M.; Macphee, C. E.; Welland, M. E. Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 15806 15811
  61. 61
    Sun, Y.; Makarava, N.; Lee, C. I.; Laksanalamai, P.; Robb, F. T.; Baskakov, I. V. J. Mol. Biol. 2008, 376, 1155 1167
  62. 62
    Khurana, R.; Ionescu-Zanetti, C.; Pope, M.; Li, J.; Nielson, L.; Ramirez-Alvarado, M.; Regan, L.; Fink, A. L.; Carter, S. A. Biophys. J. 2003, 85, 1135 1144
  63. 63
    Measey, T. J.; Schweitzer-Stenner, R. J. Am. Chem. Soc. 2010, 133, 1066 1076
  64. 64
    Welch, W. R. W.; Kubelka, J.; Keiderling, T. A. J. Phys. Chem. B 2013, 117, 10343 10358
  65. 65
    Welch, W. R. W.; Kubelka, J.; Keiderling, T. A. J. Phys. Chem. B 2013, 117, 10359 10369

Cited By

Click to copy section linkSection link copied!
Citation Statements
Explore this article's citation statements on scite.ai

This article is cited by 158 publications.

  1. Yan Wang, Yurong Zhao, Henghao Yu, Kai Qi, Zhenhua Xie, Xinfeng Ju, Muhan Wang, Yuanhao Jiang, Kate Alston, Hua He, Yubin Ke, Jiqian Wang, Kai Tao, Xuzhi Hu, Feng Zhou, Jian Ren Lu, Hai Xu. Chirality Inversion upon Coassembly of Stereoisomeric Short Peptides with Like-Handedness. ACS Nano 2025, Article ASAP.
  2. Axell Rodriguez, Yana Purvinsh, Junjie Zhang, Artem S. Rogovskyy, Dmitry Kurouski. Nano-Infrared Detection and Identification of Bacteria at the Single-Cell Level. Analytical Chemistry 2025, Article ASAP.
  3. Gennaro Pescitelli, Lorenzo Di Bari. The Phenomenon of Vibrational Circular Dichroism Enhancement: A Systematic Survey of Literature Data. The Journal of Physical Chemistry B 2024, 128 (38) , 9043-9060. https://doi.org/10.1021/acs.jpcb.4c04143
  4. Abid Ali, Mikhail Matveyenka, Axell Rodriguez, Dmitry Kurouski. Under Heparin-Free Conditions Unsaturated Phospholipids Inhibit the Aggregation of 1N4R and 2N4R Tau. The Journal of Physical Chemistry Letters 2024, 15 (33) , 8577-8583. https://doi.org/10.1021/acs.jpclett.4c01718
  5. Jia-Ge Jia, Chen-Chen Zhao, Yi-Fan Wei, Zhi-Min Zhai, Song-Song Bao, Allan J. Jacobson, Jing Ma, Li-Min Zheng. Macroscopic Helical Assembly of One-Dimensional Coordination Polymers: Helicity Inversion Triggered by Solvent Isomerism. Journal of the American Chemical Society 2023, 145 (44) , 23948-23962. https://doi.org/10.1021/jacs.3c05552
  6. Ritu Joshi, Kiryl Zhaliazka, Aidan P. Holman, Dmitry Kurouski. Elucidation of the Role of Lipids in Late Endosomes on the Aggregation of Insulin. ACS Chemical Neuroscience 2023, 14 (18) , 3551-3559. https://doi.org/10.1021/acschemneuro.3c00475
  7. Anagha C. Unnikrishnan, Kanagasabai Balamurugan, Ganesh Shanmugam. Structural Insights into the Amyloid Fibril Polymorphism Using an Isotope-Edited Vibrational Circular Dichroism Study at the Amino Acid Residue Level. The Journal of Physical Chemistry B 2023, 127 (36) , 7674-7684. https://doi.org/10.1021/acs.jpcb.3c03437
  8. Aidan P. Holman, Kimberly Quinn, Rakesh Kumar, Sebastian Kmiecik, Abid Ali, Dmitry Kurouski. Fatty Acids Reverse the Supramolecular Chirality of Insulin Fibrils. The Journal of Physical Chemistry Letters 2023, 14 (30) , 6935-6939. https://doi.org/10.1021/acs.jpclett.3c01527
  9. Mikhail Matveyenka, Kiryl Zhaliazka, Dmitry Kurouski. Concentration of Phosphatidylserine Influence Rates of Insulin Aggregation and Toxicity of Amyloid Aggregates In Vitro. ACS Chemical Neuroscience 2023, 14 (12) , 2396-2404. https://doi.org/10.1021/acschemneuro.3c00277
  10. Junyoung Kwon, Ki Hyun Park, Won Jin Choi, Nicholas A. Kotov, Jihyeon Yeom. Chiral Spectroscopy of Nanostructures. Accounts of Chemical Research 2023, 56 (12) , 1359-1372. https://doi.org/10.1021/acs.accounts.2c00756
  11. Paolo Elvati, Chloe Luyet, Yichun Wang, Changjiang Liu, J. Scott VanEpps, Nicholas A. Kotov, Angela Violi. Molecular Architecture and Helicity of Bacterial Amyloid Nanofibers: Implications for the Design of Nanoscale Antibiotics. ACS Applied Nano Materials 2023, 6 (8) , 6594-6604. https://doi.org/10.1021/acsanm.3c00174
  12. Triza Pal, Debangshu Chaudhuri. Chiral and Morphological Anisotropy of Supramolecular Polymers Shaped by a Singularity in Solvent Composition. Journal of the American Chemical Society 2023, 145 (4) , 2532-2543. https://doi.org/10.1021/jacs.2c12253
  13. Daria Ruth Galimberti. Vibrational Circular Dichroism from DFT Molecular Dynamics: The AWV Method. Journal of Chemical Theory and Computation 2022, 18 (10) , 6217-6230. https://doi.org/10.1021/acs.jctc.2c00736
  14. Payam Arghavani, Alireza Badiei, Seyyed Abolghasem Ghadami, Mehran Habibi-Rezaei, Faezeh Moosavi-Movahedi, Ladan Delphi, Ali Akbar Moosavi-Movahedi. Inhibiting mTTR Aggregation/Fibrillation by a Chaperone-like Hydrophobic Amino Acid-Conjugated SPION. The Journal of Physical Chemistry B 2022, 126 (8) , 1640-1654. https://doi.org/10.1021/acs.jpcb.1c08796
  15. Shengli Liu, Xiaoyun Ma, Mei Song, Chang-Yin Ji, Jian Song, Yinglu Ji, Sijia Ma, Jian Jiang, Xiaochun Wu, Jiafang Li, Minghua Liu, Rong-Yao Wang. Plasmonic Nanosensors with Extraordinary Sensitivity to Molecularly Enantioselective Recognition at Nanoscale Interfaces. ACS Nano 2021, 15 (12) , 19535-19545. https://doi.org/10.1021/acsnano.1c06467
  16. Hisako Sato, Akihiko Yamagishi, Masaru Shimizu, Keisuke Watanabe, Jun Koshoubu, Jun Yoshida, Izuru Kawamura. Mapping of Supramolecular Chirality in Insect Wings by Microscopic Vibrational Circular Dichroism Spectroscopy: Heterogeneity in Protein Distribution. The Journal of Physical Chemistry Letters 2021, 12 (32) , 7733-7737. https://doi.org/10.1021/acs.jpclett.1c01949
  17. Yuefei Wang, Qing Li, Jiaxing Zhang, Wei Qi, Shengping You, Rongxin Su, Zhimin He. Self-Templated, Enantioselective Assembly of an Amyloid-like Dipeptide into Multifunctional Hierarchical Helical Arrays. ACS Nano 2021, 15 (6) , 9827-9840. https://doi.org/10.1021/acsnano.1c00746
  18. Muhan Wang, Yurong Zhao, Limin Zhang, Jing Deng, Kai Qi, Peng Zhou, Xiaoyue Ma, Dong Wang, Zhen Li, Jiqian Wang, Jun Yang, Jian R. Lu, Jun Zhang, Hai Xu. Unexpected Role of Achiral Glycine in Determining the Suprastructural Handedness of Peptide Nanofibrils. ACS Nano 2021, 15 (6) , 10328-10341. https://doi.org/10.1021/acsnano.1c02547
  19. Jiangtao Zhou, Leonardo Venturelli, Ludovic Keiser, Sergey K. Sekatskii, François Gallaire, Sandor Kasas, Giovanni Longo, Tuomas P. J. Knowles, Francesco S. Ruggeri, Giovanni Dietler. Environmental Control of Amyloid Polymorphism by Modulation of Hydrodynamic Stress. ACS Nano 2021, 15 (1) , 944-953. https://doi.org/10.1021/acsnano.0c07570
  20. Gianluigi Albano, Gennaro Pescitelli, Lorenzo Di Bari. Chiroptical Properties in Thin Films of π-Conjugated Systems. Chemical Reviews 2020, 120 (18) , 10145-10243. https://doi.org/10.1021/acs.chemrev.0c00195
  21. Yuqi Fan, Qiguo Xing, Jiaxing Zhang, Yuefei Wang, Yaoyu Liang, Wei Qi, Rongxin Su, Zhimin He. Self-Assembly of Peptide Chiral Nanostructures with Sequence-Encoded Enantioseparation Capability. Langmuir 2020, 36 (35) , 10361-10370. https://doi.org/10.1021/acs.langmuir.0c01338
  22. Tianyi Dou, Zhandong Li, Junjie Zhang, Alex Evilevitch, Dmitry Kurouski. Nanoscale Structural Characterization of Individual Viral Particles Using Atomic Force Microscopy Infrared Spectroscopy (AFM-IR) and Tip-Enhanced Raman Spectroscopy (TERS). Analytical Chemistry 2020, 92 (16) , 11297-11304. https://doi.org/10.1021/acs.analchem.0c01971
  23. Caitlyn R. Fields, Sidney S. Dicke, Megan K. Petti, Martin T. Zanni, Justin P. Lomont. A Different hIAPP Polymorph Is Observed in Human Serum Than in Aqueous Buffer: Demonstration of a New Method for Studying Amyloid Fibril Structure Using Infrared Spectroscopy. The Journal of Physical Chemistry Letters 2020, 11 (15) , 6382-6388. https://doi.org/10.1021/acs.jpclett.0c01345
  24. Xiaoqiu Dou, Nabila Mehwish, Changli Zhao, Jinying Liu, Chao Xing, Chuanliang Feng. Supramolecular Hydrogels with Tunable Chirality for Promising Biomedical Applications. Accounts of Chemical Research 2020, 53 (4) , 852-862. https://doi.org/10.1021/acs.accounts.0c00012
  25. Timothy A. Keiderling. Structure of Condensed Phase Peptides: Insights from Vibrational Circular Dichroism and Raman Optical Activity Techniques. Chemical Reviews 2020, 120 (7) , 3381-3419. https://doi.org/10.1021/acs.chemrev.9b00636
  26. McKensie L. Mason, Remy F. Lalisse, Tyler J. Finnegan, Christopher M. Hadad, David A. Modarelli, Jon R. Parquette. pH-Controlled Chiral Packing and Self-Assembly of a Coumarin Tetrapeptide. Langmuir 2019, 35 (38) , 12460-12468. https://doi.org/10.1021/acs.langmuir.9b01939
  27. Benjamin Martial, Thierry Lefèvre, Thierry Buffeteau, Michèle Auger. Vibrational Circular Dichroism Reveals Supramolecular Chirality Inversion of α-Synuclein Peptide Assemblies upon Interactions with Anionic Membranes. ACS Nano 2019, 13 (3) , 3232-3242. https://doi.org/10.1021/acsnano.8b08932
  28. Monika Krupová, Josef Kapitán, Petr Bouř. Induced Lanthanide Circularly Polarized Luminescence as a Probe of Protein Fibrils. ACS Omega 2019, 4 (1) , 1265-1271. https://doi.org/10.1021/acsomega.8b03175
  29. Qiguo Xing, Jiaxing Zhang, Yanyan Xie, Yuefei Wang, Wei Qi, Hengjun Rao, Rongxin Su, Zhimin He. Aromatic Motifs Dictate Nanohelix Handedness of Tripeptides. ACS Nano 2018, 12 (12) , 12305-12314. https://doi.org/10.1021/acsnano.8b06173
  30. Evelien Van de Vondel, Pieter Baatsen, Roos Van Elzen, Anne-Marie Lambeir, Timothy A. Keiderling, Wouter A. Herrebout, Christian Johannessen. Vibrational Circular Dichroism Sheds New Light on the Competitive Effects of Crowding and β-Synuclein on the Fibrillation Process of α-Synuclein. Biochemistry 2018, 57 (41) , 5989-5995. https://doi.org/10.1021/acs.biochem.8b00780
  31. Mary Rose Hilaire, Bei Ding, Debopreeti Mukherjee, Jianxin Chen, and Feng Gai . Possible Existence of α-Sheets in the Amyloid Fibrils Formed by a TTR105–115 Mutant. Journal of the American Chemical Society 2018, 140 (2) , 629-635. https://doi.org/10.1021/jacs.7b09262
  32. Aditya Iyer, Steven J. Roeters, Vladimir Kogan, Sander Woutersen, Mireille M. A. E Claessens, and Vinod Subramaniam . C-Terminal Truncated α-Synuclein Fibrils Contain Strongly Twisted β-Sheets. Journal of the American Chemical Society 2017, 139 (43) , 15392-15400. https://doi.org/10.1021/jacs.7b07403
  33. Timur Shaykhutdinov, Simona D. Pop, Andreas Furchner, and Karsten Hinrichs . Supramolecular Orientation in Anisotropic Assemblies by Infrared Nanopolarimetry. ACS Macro Letters 2017, 6 (6) , 598-602. https://doi.org/10.1021/acsmacrolett.7b00147
  34. Jun Lu, Yi-Xin Chang, Ning-Ning Zhang, Ying Wei, Ai-Ju Li, Jia Tai, Yao Xue, Zhao-Yi Wang, Yang Yang, Li Zhao, Zhong-Yuan Lu, and Kun Liu . Chiral Plasmonic Nanochains via the Self-Assembly of Gold Nanorods and Helical Glutathione Oligomers Facilitated by Cetyltrimethylammonium Bromide Micelles. ACS Nano 2017, 11 (4) , 3463-3475. https://doi.org/10.1021/acsnano.6b07697
  35. Meng Wang, Peng Zhou, Jiqian Wang, Yurong Zhao, Hongchao Ma, Jian R. Lu, and Hai Xu . Left or Right: How Does Amino Acid Chirality Affect the Handedness of Nanostructures Self-Assembled from Short Amphiphilic Peptides?. Journal of the American Chemical Society 2017, 139 (11) , 4185-4194. https://doi.org/10.1021/jacs.7b00847
  36. Richard Haburcak, Junfeng Shi, Xuewen Du, Dan Yuan, and Bing Xu . Ligand–Receptor Interaction Modulates the Energy Landscape of Enzyme-Instructed Self-Assembly of Small Molecules. Journal of the American Chemical Society 2016, 138 (47) , 15397-15404. https://doi.org/10.1021/jacs.6b07677
  37. Eiji Yashima, Naoki Ousaka, Daisuke Taura, Kouhei Shimomura, Tomoyuki Ikai, and Katsuhiro Maeda . Supramolecular Helical Systems: Helical Assemblies of Small Molecules, Foldamers, and Polymers with Chiral Amplification and Their Functions. Chemical Reviews 2016, 116 (22) , 13752-13990. https://doi.org/10.1021/acs.chemrev.6b00354
  38. Myungshim Kang, Pengcheng Zhang, Honggang Cui, and Sharon M. Loverde . π–π Stacking Mediated Chirality in Functional Supramolecular Filaments. Macromolecules 2016, 49 (3) , 994-1001. https://doi.org/10.1021/acs.macromol.5b02148
  39. Ge Zhang, Viktoria Babenko, Wojciech Dzwolak, and Timothy A. Keiderling . Dimethyl Sulfoxide Induced Destabilization and Disassembly of Various Structural Variants of Insulin Fibrils Monitored by Vibrational Circular Dichroism. Biochemistry 2015, 54 (49) , 7193-7202. https://doi.org/10.1021/acs.biochem.5b00809
  40. Minghua Liu, Li Zhang, and Tianyu Wang . Supramolecular Chirality in Self-Assembled Systems. Chemical Reviews 2015, 115 (15) , 7304-7397. https://doi.org/10.1021/cr500671p
  41. Maruda Shanmugasundaram, Dmitry Kurouski, William Wan, Gerald Stubbs, Rina K. Dukor, Laurence A. Nafie, and Igor K. Lednev . Rapid Filament Supramolecular Chirality Reversal of HET-s (218–289) Prion Fibrils Driven by pH Elevation. The Journal of Physical Chemistry B 2015, 119 (27) , 8521-8525. https://doi.org/10.1021/acs.jpcb.5b04779
  42. Yuefei Wang, Wei Qi, Renliang Huang, Xuejiao Yang, Mengfan Wang, Rongxin Su, and Zhimin He . Rational Design of Chiral Nanostructures from Self-Assembly of a Ferrocene-Modified Dipeptide. Journal of the American Chemical Society 2015, 137 (24) , 7869-7880. https://doi.org/10.1021/jacs.5b03925
  43. Roman Marty, Holger Frauenrath, and Jan Helbing . Aggregates from Perylene Bisimide Oligopeptides as a Test Case for Giant Vibrational Circular Dichroism. The Journal of Physical Chemistry B 2014, 118 (38) , 11152-11160. https://doi.org/10.1021/jp506837c
  44. Shiwei Wang, Zhen He, Xiaolin Duan, Lulu He, Jie Xing, Aiguo Wu, Juan Li. Chiral helical peptide nanomaterials: Construction strategies and applications. Nano Today 2025, 62 , 102703. https://doi.org/10.1016/j.nantod.2025.102703
  45. Katarzyna Pajor, Monika Halat, Joanna E. Rode, Malgorzata Baranska. Raman Optical Activity Enhanced via Supramolecular Aggregation and Other Intermolecular Interactions—A Review. Chemistry – A European Journal 2025, 115 https://doi.org/10.1002/chem.202500394
  46. Oliwia Polańska, Natalia Szulc, Witold Dyrka, Alicja W. Wojciechowska, Małgorzata Kotulska, Andrzej M. Żak, Marlena E. Gąsior-Głogowska, Monika Szefczyk. Environmental sensitivity of amyloidogenic motifs in fungal NOD-like receptor-mediated immunity: Molecular and structural insights into amyloid assembly. International Journal of Biological Macromolecules 2025, 304 , 140773. https://doi.org/10.1016/j.ijbiomac.2025.140773
  47. Monika Krupová, Valery Andrushchenko. Vibrational circular dichroism beyond solutions. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2025, 32 , 125839. https://doi.org/10.1016/j.saa.2025.125839
  48. Takahiro Watanabe, Priyanka Swaminathan, Linnea Björk, Ayaka Nakanishi, Hisako Sato, Tamotsu Zako, K. P. R. Nilsson, Mikael Lindgren. Spectroscopic Response of Chiral Proteophenes Binding to Two Chiral Insulin Amyloids. ChemPhotoChem 2025, 9 (1) https://doi.org/10.1002/cptc.202400225
  49. William W. Parson, Clemens Burda. Zirkulardichroismus. 2025, 479-517. https://doi.org/10.1007/978-3-031-52100-3_9
  50. Stephen J. Klawa, Michelle Lee, Kyle D. Riker, Tengyue Jian, Qunzhao Wang, Yuan Gao, Margaret L. Daly, Shreeya Bhonge, W. Seth Childers, Tolulope O. Omosun, Anil K. Mehta, David G. Lynn, Ronit Freeman. Uncovering supramolecular chirality codes for the design of tunable biomaterials. Nature Communications 2024, 15 (1) https://doi.org/10.1038/s41467-024-45019-2
  51. Kuo Fu, Yanli Zhao, Guofeng Liu. Pathway-directed recyclable chirality inversion of coordinated supramolecular polymers. Nature Communications 2024, 15 (1) https://doi.org/10.1038/s41467-024-53928-5
  52. Alp Yigit Özdemir, Kateřina Hofbauerová, Vladimír Kopecký, Jiří Novotný, Vladimír Rudajev. Different amyloid β42 preparations induce different cell death pathways in the model of SH-SY5Y neuroblastoma cells. Cellular & Molecular Biology Letters 2024, 29 (1) https://doi.org/10.1186/s11658-024-00657-8
  53. Ashwathanarayana Gowda, Gourab Acharjee, Suraj Kumar Pathak, Grace A. R. Rohaley, Asmita Shah, Robert P. Lemieux, Marianne E. Prévôt, Torsten Hegmann. Controlling nano- and microfilament morphology by strategically placing chiral centers in the side chains of bent-core molecules. Materials Horizons 2024, 11 (22) , 5550-5563. https://doi.org/10.1039/D4MH01243G
  54. Zuzanna Majka, Karolina Kwiecień, Agnieszka Kaczor. Vibrational Optical Activity of Amyloid Fibrils. ChemPlusChem 2024, 89 (8) https://doi.org/10.1002/cplu.202400091
  55. Natalia V. Kuzmina, Anastasia A. Gavrilova, Anna S. Fefilova, Anna E. Romanovich, Irina M. Kuznetsova, Konstantin K. Turoverov, Alexander V. Fonin. Von-Hippel Lindau protein amyloid formation. The role of GST-tag. Biochemical and Biophysical Research Communications 2024, 715 , 150008. https://doi.org/10.1016/j.bbrc.2024.150008
  56. Dinesh Kumar Duraisamy, Samala Murali Mohan Reddy, Puchalapalli Saveri, Abhijit P. Deshpande, Ganesh Shanmugam. A Unique Temperature‐Induced Reverse Supramolecular Chirality‐Assisted Gel‐to‐Gel Transition. Macromolecular Rapid Communications 2024, 45 (10) https://doi.org/10.1002/marc.202400018
  57. Kai Tao, Haoran Wu, Lihi Adler-Abramovich, Jiahao Zhang, Xinyuan Fan, Yunxiao Wang, Yan Zhang, Syed A.M. Tofail, Deqing Mei, Junbai Li, Ehud Gazit. Aromatic short peptide architectonics: Assembly and engineering. Progress in Materials Science 2024, 142 , 101240. https://doi.org/10.1016/j.pmatsci.2024.101240
  58. Zhenxu Yang, Arun Jaiswal, Qiankun Yin, Xiaoqi Lin, Lu Liu, Jiarong Li, Xiaochen Liu, Zhejun Xu, Jiao Jiao Li, Ken-Tye Yong. Chiral nanomaterials in tissue engineering. Nanoscale 2024, 16 (10) , 5014-5041. https://doi.org/10.1039/D3NR05003C
  59. Abid Ali, Kiryl Zhaliazka, Aidan P. Holman, Dmitry Kurouski. Secondary structure and toxicity of lysozyme fibrils are determined by the length and unsaturation of phosphatidic acid. Proteins: Structure, Function, and Bioinformatics 2024, 92 (3) , 411-417. https://doi.org/10.1002/prot.26622
  60. Abid Ali, Tianyi Dou, Aidan P. Holman, Andrew Hung, Luke Osborne, Davis Pickett, Axell Rodriguez, Kiryl Zhaliazka, Dmitry Kurouski. The influence of zwitterionic and anionic phospholipids on protein aggregation. Biophysical Chemistry 2024, 306 , 107174. https://doi.org/10.1016/j.bpc.2024.107174
  61. Min Wu, Jose Miguel Flores-Fernandez, YongLiang Wang, Haseeb Ahmed, Holger Wille, Maria Stepanova. SERS probing of fungal HET-s fibrils formed at neutral and acidic pH conditions. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2024, 309 , 123817. https://doi.org/10.1016/j.saa.2023.123817
  62. Ashwathanarayana Gowda, Suraj Kumar Pathak, Grace A. R. Rohaley, Gourab Acharjee, Andrea Oprandi, Ryan Williams, Marianne E. Prévôt, Torsten Hegmann. Organic chiral nano- and microfilaments: types, formation, and template applications. Materials Horizons 2024, 11 (2) , 316-340. https://doi.org/10.1039/D3MH01390A
  63. Hisako Sato, Jun Yoshida, Akihiko Yamagishi. VCD of Biological Substances: Effects of d-Amino Acid Residues on Supramolecular Chirality. 2024, 163-178. https://doi.org/10.1007/978-981-97-0391-3_13
  64. Natalia Hachlica, Aleksandra Kolodziejczyk, Michal Rawski, Marcin Górecki, Aleksandra Wajda, Agnieszka Kaczor. “Nature or nurture” – How environmental factors influence the conformational memory of amyloid fibrils. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2024, 304 , 123293. https://doi.org/10.1016/j.saa.2023.123293
  65. K. Dobšíková, T. Taušová, P. Fagan, N. Paškanová, M. Kuchař, J. Čejka, V. Setnička. Solid-state vibrational circular dichroism: Methodology and application for amphetamine derivatives. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2024, 305 , 123486. https://doi.org/10.1016/j.saa.2023.123486
  66. Abid Ali, Kiryl Zhaliazka, Tianyi Dou, Aidan P. Holman, Rakesh Kumar, Dmitry Kurouski. Secondary structure and toxicity of transthyretin fibrils can be altered by unsaturated fatty acids. International Journal of Biological Macromolecules 2023, 253 , 127241. https://doi.org/10.1016/j.ijbiomac.2023.127241
  67. Leonardo A. Linhares, Carlos H. I. Ramos. Unlocking Insights into Folding, Structure, and Function of Proteins through Circular Dichroism Spectroscopy—A Short Review. Applied Biosciences 2023, 2 (4) , 639-655. https://doi.org/10.3390/applbiosci2040040
  68. Sascha Jähnigen. Vibrational Circular Dichroism Spectroscopy of Chiral Molecular Crystals: Insights from Theory. Angewandte Chemie 2023, 135 (41) https://doi.org/10.1002/ange.202303595
  69. Sascha Jähnigen. Vibrational Circular Dichroism Spectroscopy of Chiral Molecular Crystals: Insights from Theory. Angewandte Chemie International Edition 2023, 62 (41) https://doi.org/10.1002/anie.202303595
  70. Hao Qi, Kai Qi, Jie Li, Chunyong He, Mingrui Liao, Xuzhi Hu, Yurong Zhao, Yubin Ke, Chunqiu Zhang, Jun Zhang, Jiqian Wang, Jian R. Lu, Hai Xu. The role of aromatic residues in controlling the supramolecular chirality of short amphiphilic peptides. Nano Research 2023, 16 (10) , 12230-12237. https://doi.org/10.1007/s12274-023-5783-y
  71. Boris Noskov, Giuseppe Loglio, Reinhard Miller, Olga Milyaeva, Maria Panaeva, Alexey Bykov. Dynamic Surface Properties of α-Lactalbumin Fibril Dispersions. Polymers 2023, 15 (19) , 3970. https://doi.org/10.3390/polym15193970
  72. Chinmaya Panda, Sachin Kumar, Sharad Gupta, Lalit M Pandey. Structural, kinetic, and thermodynamic aspects of insulin aggregation. Physical Chemistry Chemical Physics 2023, 25 (36) , 24195-24213. https://doi.org/10.1039/D3CP03103A
  73. Aleksandra Kolodziejczyk, Laurence A. Nafie, Aleksandra Wajda, Agnieszka Kaczor. Exceptionally enhanced Raman optical activity (ROA) of amyloid fibrils and their prefibrillar states. Chemical Communications 2023, 59 (72) , 10793-10796. https://doi.org/10.1039/D3CC03216G
  74. Agnieszka Kaczor. Chirality induction and amplification in supramolecular systems exhibiting vibrational optical activity. Physical Chemistry Chemical Physics 2023, 25 (29) , 19371-19379. https://doi.org/10.1039/D3CP01961F
  75. Guofeng Liu, Mark G. Humphrey, Chi Zhang, Yanli Zhao. Self-assembled stereomutation with supramolecular chirality inversion. Chemical Society Reviews 2023, 52 (13) , 4443-4487. https://doi.org/10.1039/D2CS00476C
  76. Sijia He, Zichao Jiang, Xiaoqiu Dou, Laiben Gao, Chuanliang Feng. Chiral Supramolecular Assemblies: Controllable Construction and Biological Activity. ChemPlusChem 2023, 88 (7) https://doi.org/10.1002/cplu.202300226
  77. Shuqing Zhang, Aiyou Hao, Pengyao Xing. Solvent-resolved self-assemblies of cholesteryl–cyanostilbene conjugates with photo- and thermo-responsiveness. Nanoscale 2023, 15 (21) , 9567-9576. https://doi.org/10.1039/D3NR01056B
  78. Helena Vilaça, André Carvalho, Tarsila Castro, Elisabete M. S. Castanheira, Loic Hilliou, Ian Hamley, Manuel Melle-Franco, Paula M. T. Ferreira, José A. Martins. Unveiling the Role of Capping Groups in Naphthalene N-Capped Dehydrodipeptide Hydrogels. Gels 2023, 9 (6) , 464. https://doi.org/10.3390/gels9060464
  79. Natalia Hachlica, Michal Rawski, Marcin Górecki, Aleksandra Wajda, Agnieszka Kaczor. Chiral and Structural Polymorphism of Fibril Architectures of Homologous Lysozymes. Chemistry – A European Journal 2023, 29 (30) https://doi.org/10.1002/chem.202203827
  80. Kiryl Zhaliazka, Valeryia Serada, Mikhail Matveyenka, Stanislav Rizevsky, Dmitry Kurouski. Protein-to-lipid ratio uniquely changes the rate of lysozyme aggregation but does not significantly alter toxicity of mature protein aggregates. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2023, 1868 (5) , 159305. https://doi.org/10.1016/j.bbalip.2023.159305
  81. Kiryl Zhaliazka, Dmitry Kurouski. Nanoscale imaging of individual amyloid aggregates extracted from brains of Alzheimer and Parkinson patients reveals presence of lipids in α‐synuclein but not in amyloid β 1–42 fibrils. Protein Science 2023, 32 (4) https://doi.org/10.1002/pro.4598
  82. Olga Makshakova, Liliya Bogdanova, Dzhigangir Faizullin, Diliara Khaibrakhmanova, Sufia Ziganshina, Elena Ermakova, Yuriy Zuev, Igor Sedov. The Ability of Some Polysaccharides to Disaggregate Lysozyme Amyloid Fibrils and Renature the Protein. Pharmaceutics 2023, 15 (2) , 624. https://doi.org/10.3390/pharmaceutics15020624
  83. Huajie Zhu, Yufang Wang, Laurence A. Nafie. Computational methods and points for attention in absolute configuration determination. Frontiers in Natural Products 2023, 1 https://doi.org/10.3389/fntpr.2022.1086897
  84. Thomas Skamris, Bente Vestergaard, Kenneth L. Madsen, Annette E. Langkilde, Vito Foderà. Identifying Biological and Biophysical Features of Different Maturation States of α-Synuclein Amyloid Fibrils. 2023, 321-344. https://doi.org/10.1007/978-1-0716-2597-2_22
  85. William W. Parson, Clemens Burda. Circular Dichroism. 2023, 445-481. https://doi.org/10.1007/978-3-031-17222-9_9
  86. Ting Hou, Lan-Qing Wu, Yan Xu, Song-Song Bao, Li-Min Zheng. pH and Salt-Assisted Macroscopic Chirality Inversion of Gadolinium Coordination Polymer. Molecules 2023, 28 (1) , 163. https://doi.org/10.3390/molecules28010163
  87. Stanislav Rizevsky, Kiryl Zhaliazka, Mikhail Matveyenka, Kimberly Quinn, Dmitry Kurouski. Lipids reverse supramolecular chirality and reduce toxicity of amyloid fibrils. The FEBS Journal 2022, 289 (23) , 7537-7544. https://doi.org/10.1111/febs.16564
  88. Marzena Krzek, Sander Stroobants, Pierre Gelin, Wim De Malsche, Dominique Maes. Influence of Centrifugation and Shaking on the Self-Assembly of Lysozyme Fibrils. Biomolecules 2022, 12 (12) , 1746. https://doi.org/10.3390/biom12121746
  89. Yuefei Wang, Dongzhao Hao, Jiayu Liu, Qing Li, Zixuan Wang, Xi Rong, Wei Qi, Rongxin Su, Zhimin He. Self-assembly of Fibonacci number spirals in amyloid-like nanofibril films. Science China Materials 2022, 65 (11) , 3150-3156. https://doi.org/10.1007/s40843-022-2087-3
  90. Mikhail Matveyenka, Kiryl Zhaliazka, Stanislav Rizevsky, Dmitry Kurouski. Lipids uniquely alter secondary structure and toxicity of lysozyme aggregates. The FASEB Journal 2022, 36 (10) https://doi.org/10.1096/fj.202200841R
  91. Xueqian Wang, Beibei Wu, Yaqian Zhang, Chuanliang Feng. Chiral graphene-based supramolecular hydrogels toward tumor therapy. Polymer Chemistry 2022, 13 (12) , 1685-1694. https://doi.org/10.1039/D1PY01724A
  92. Joanna E. Rode, Krzysztof Lyczko, Katarzyna Kosińska, Joanna Matalińska, Jolanta Dyniewicz, Aleksandra Misicka, Jan Cz. Dobrowolski, Piotr F.J. Lipiński. The solid state VCD of a novel N-acylhydrazone trifluoroacetate. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2022, 269 , 120761. https://doi.org/10.1016/j.saa.2021.120761
  93. Jiaxing Zhang, Qing Li, Yuefei Wang, Dongzhao Hao, Wei Qi, Rongxin Su, Zhimin He. Topology‐Induced Chiral Amplification and Inversion in Self‐Assembling Dipeptide Films. Advanced Materials Interfaces 2022, 9 (6) https://doi.org/10.1002/admi.202102089
  94. Meijun Li, Minghua Liu, Yinlin Sha. Induced and Inversed Circularly Polarized Luminescence of Achiral Thioflavin T Assembled on Peptide Fibril. Small 2022, 18 (8) https://doi.org/10.1002/smll.202106130
  95. Lan‐Qing Wu, Yan Xu, Ting Hou, Jia‐Ge Jia, Xin‐Da Huang, Guo‐Guo Weng, Song‐Song Bao, Li‐Min Zheng. Controllable Macroscopic Chirality of Coordination Polymers through pH and Anion‐Mediated Weak Interactions. Chemistry – A European Journal 2021, 27 (67) , 16722-16734. https://doi.org/10.1002/chem.202102954
  96. Yuhe Shen, Yuefei Wang, Ian W. Hamley, Wei Qi, Rongxin Su, Zhimin He. Chiral self-assembly of peptides: Toward the design of supramolecular polymers with enhanced chemical and biological functions. Progress in Polymer Science 2021, 123 , 101469. https://doi.org/10.1016/j.progpolymsci.2021.101469
  97. Christian Code, Morten Frendø Ebbesen, Rohit Sood, Paavo K.J. Kinnunen. Activation of phospholipase A2 by prostaglandin in vitro. Prostaglandins & Other Lipid Mediators 2021, 152 , 106500. https://doi.org/10.1016/j.prostaglandins.2020.106500
  98. Monika Krupová, Jiří Kessler, Petr Bouř. Polymorphism of Amyloid Fibrils Induced by Catalytic Seeding: A Vibrational Circular Dichroism Study. ChemPhysChem 2021, 22 (1) , 83-91. https://doi.org/10.1002/cphc.202000797
  99. Lena Ostermeier, Guilherme A.P. de Oliveira, Wojciech Dzwolak, Jerson L. Silva, Roland Winter. Exploring the polymorphism, conformational dynamics and function of amyloidogenic peptides and proteins by temperature and pressure modulation. Biophysical Chemistry 2021, 268 , 106506. https://doi.org/10.1016/j.bpc.2020.106506
  100. Robert Dec, Marcin Guza, Wojciech Dzwolak. Reduction of a disulfide-constrained oligo-glutamate peptide triggers self-assembly of β2-type amyloid fibrils with the chiroptical properties determined by supramolecular chirality. International Journal of Biological Macromolecules 2020, 162 , 866-872. https://doi.org/10.1016/j.ijbiomac.2020.06.221
Load all citations

Journal of the American Chemical Society

Cite this: J. Am. Chem. Soc. 2014, 136, 6, 2302–2312
Click to copy citationCitation copied!
https://doi.org/10.1021/ja407583r
Published January 9, 2014

Copyright © 2014 American Chemical Society. This publication is licensed under these Terms of Use.

Article Views

5138

Altmetric

-

Citations

Learn about these metrics

Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.

Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.

The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated.

  • Abstract

    Figure 1

    Figure 1. VCD (a) and IR (b) spectra of lysozyme fibrils grown at pH 1.0 (blue), 1.5 (green), 2.3 (black), and 2.7 (red) for 3 days at 65 °C.

    Figure 2

    Figure 2. SEM (a, c) and fluid-cell AFM (b, d) images of reversed VCD (a, b) and normal VCD (c and d) lysozyme fibrils grown at 65 °C for 3 days. Helical twisted fibrils (all left-handed) are indicated by yellow arrows. Scale bars are 100 nm.

    Figure 3

    Figure 3. VCD (top) and IR (bottom) spectra of apo-α-lactalbumin fibrils grown at pH 1.5 (blue), 2.5 (green), 3.0 (black), and 4.0 (red) for 3 days at 37 °C.

    Figure 4

    Figure 4. Fluid-cell AFM images of left-twisted (a) and tape-like (b) fibrils of apo-α-lactalbumin grown for 3 days at 37 °C.

    Figure 5

    Figure 5. VCD (a) and IR (b) spectra of HET-s (218–289) fibrils grown at pH 2.0 (blue), 3.3 (green), and 3.9 (black) for 2 months at room temperature. For better visualization of band positions and intensities the insert shows VCD spectra of only pH 3.3 (green) and pH 3.9 (black) fibrils.

    Figure 6

    Figure 6. AFM images of HET-s (218–289) prion fibrils grown in pH 2.0 (a) and 3.9 (b).

    Figure 7

    Figure 7. VCD (top) and IR (bottom) spectra of TTR (105–115) fibrils grown at pH 1.0 (blue), 1.5 (green), 2.0 (black), 2.5 (red), and 3.0 (violet) for 2 days at 37 °C followed by 14 days at room temperature.

    Figure 8

    Figure 8. AFM images of TTR (105–115) fibrils grown at (a) pH 1.5 and (b) pH 2.5. Scale bar is 100 nm.

    Figure 9

    Figure 9. Diagram illustrating the progression from folded protein to individual straight filament with chirality below the senstivity of AFM/SEM and on to mature multifilament fibrils with right helical filaments forming flat tape-like fibrils of straight filaments and left helical filaments forming, possibly more stable, left twisted braids of filaments. The pH dependence may vary between proteins/peptides but not the VCD intensity patterns (normal left helical filaments versus reversed for right helical filaments).

  • References


    This article references 65 other publications.

    1. 1
      Dobson, C. M. Nature 2003, 426, 884 890
    2. 2
      Makarava, N.; Baskakov, I. V. J. Biol. Chem. 2008, 283, 15988 15996
    3. 3
      Goldsbury, C. S.; Wirtz, S.; Muller, S. A.; Sunderji, S.; Wicki, P.; Aebi, U.; Frey, P. J. Struct. Biol. 2000, 130, 217 231
    4. 4
      Dische, F. E.; Wernstedt, C.; Westermark, G. T.; Westermark, P.; Pepys, M. B.; Rennie, J. A.; Gilbey, S. G.; Watkins, P. J. Diabetologia 1988, 31, 158 161
    5. 5
      Chiti, F.; Dobson, C. M. Annu. Rev. Biochem. 2006, 75, 333 366
    6. 6
      Dobson, C. M. Trends Biochem. Sci. 1999, 24, 329 332
    7. 7
      Jansen, R.; Grudzielanek, S.; Dzwolak, W.; Winter, R. J. Mol. Biol. 2004, 338, 203 206
    8. 8
      Jimenez, J. L.; Nettleton, E. J.; Bouchard, M.; Robinson, C. V.; Dobson, C. M.; Saibil, H. R. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 9196 9201
    9. 9
      Bauer, H. H.; Aebi, U.; Haner, M.; Hermann, R.; Muller, M.; Merkle, H. P. J. Struct. Biol. 1995, 115, 1 15
    10. 10
      Goldsbury, C. S.; Cooper, G. J.; Goldie, K. N.; Muller, S. A.; Saafi, E. L.; Gruijters, W. T.; Misur, M. P.; Engel, A.; Aebi, U.; Kistler, J. J. Struct. Biol. 1997, 119, 17 27
    11. 11
      Cardoso, I.; Goldsbury, C. S.; Muller, S. A.; Olivieri, V.; Wirtz, S.; Damas, A. M.; Aebi, U.; Saraiva, M. J. J. Mol. Biol. 2002, 317, 683 695
    12. 12
      Anderson, M.; Bocharova, O. V.; Makarava, N.; Breydo, L.; Salnikov, V. V.; Baskakov, I. V. J. Mol. Biol. 2006, 358, 580 596
    13. 13
      Paravastu, A. K.; Leapman, R. D.; Yau, W. M.; Tycko, R. Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 18349 18354
    14. 14
      Wischik, C. M.; Novak, M.; Thogersen, H. C.; Edwards, P. C.; Runswick, M. J.; Jakes, R.; Walker, J. E.; Milstein, C.; Roth, M.; Klug, A. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 4506 4510
    15. 15
      Luhrs, T.; Ritter, C.; Adrian, M.; Riek-Loher, D.; Bohrmann, B.; Dobeli, H.; Schubert, D.; Riek, R. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 17342 17347
    16. 16
      Adamcik, J.; Mezzenga, R. Soft Matter 2011, 7, 5437 5443
    17. 17
      Petkova, A. T.; Leapman, R. D.; Guo, Z.; Yau, W.-M.; Mattson, M. P.; Tycko, R. Science 2005, 307, 262 265
    18. 18
      Dzwolak, W.; Pecul, M. FEBS Lett. 2005, 579, 6601 6603
    19. 19
      Dzwolak, W.; Loksztejn, A.; Galinska-Rakoczy, A.; Adachi, R.; Goto, Y.; Rupnicki, L. J. Am. Chem. Soc. 2007, 129, 7517 7522
    20. 20
      Loksztejn, A.; Dzwolak, W. J. Mol. Biol. 2008, 379, 9 16
    21. 21
      Nafie, L. A. Vibrational Optical Activity: Principles and Applications; Wiley: Chichester, U.K., 2011.
    22. 22
      Ma, S.; Cao, X.; Mak, M.; Sadik, A.; Walkner, C.; Freedman, T. B.; Lednev, I. K.; Dukor, R. K.; Nafie, L. A. J. Am. Chem. Soc. 2007, 129, 12364 12365
    23. 23
      Kurouski, D.; Lombardi, R. A.; Dukor, R. K.; Lednev, I. K.; Nafie, L. A. Chem. Commun. 2010, 46, 7154 7156
    24. 24
      Kurouski, D.; Dukor, R.; Lu, X.; Nafie, L. A.; Lednev, I. K. Biophys. J. 2012, 103, 522 531
    25. 25
      Kurouski, D.; Dukor, R. K.; Lu, X.; Nafie, L. A.; Lednev, I. K. Chem. Commun. 2012, 48, 2837 2839
    26. 26
      Shashilov, V.; Xu, M.; Ermolenkov, V. V.; Fredriksen, L.; Lednev, I. K. J. Am. Chem. Soc. 2007, 129, 6972 6973
    27. 27
      Xu, M.; Ermolenkov, V. V.; He, W.; Uversky, V. N.; Fredriksen, L.; Lednev, I. K. Biopolymers 2005, 79, 58 61
    28. 28
      Xu, M.; Ermolenkov, V. V.; Uversky, V. N.; Lednev, I. K. J. Biophotonics 2008, 1, 215 229
    29. 29
      Jackson, M.; Mantsch, H. H. Crit. Rev. Biochem. Mol. Biol. 1995, 30, 95 120
    30. 30
      Rubin, N.; Perugia, E.; Goldschmidt, M.; Fridkin, M.; Addadi, L. J. Am. Chem. Soc. 2008, 130, 4602 4603
    31. 31
      Lara, C.; Adamcik, J.; Jordens, S.; Mezzenga, R. Biomacromolecules 2011, 12, 1868 1875
    32. 32
      Rubin, N.; Perugia, E.; Wolf, S. G.; Klein, E.; Fridkin, M.; Addadi, L. J. Am. Chem. Soc. 2010, 132, 4242 4248
    33. 33
      Lednev, I. K. In Protein Structures, Methods in Protein Structures and Stability Analysis; Uversky, V. N.; Permyakov, E. A., Eds.; Nova Sci.: New York, 2007; pp 1 26.
    34. 34
      Arnaud, C. Chem. Eng. News 2009, 87, 10 14
    35. 35
      Xu, M.; Shashilov, V.; Lednev, I. K. J. Am. Chem. Soc. 2007, 129, 11002 11003
    36. 36
      Shashilov, V. A.; Lednev, I. K. J. Am. Chem. Soc. 2008, 130, 309 317
    37. 37
      Sikirzhytski, V.; Topilina, N. I.; Higashiya, S.; Welch, J. T.; Lednev, I. K. J. Am. Chem. Soc. 2008, 130, 5852 5853
    38. 38
      Olapedo, S. A..; Xiong, K.; Hong, Z.; Asher, S. A.; Handen, J.; Lednev, I. K. Chem. Rev. 2012, 112, 2604 2628
    39. 39
      Shashilov, V. A.; Sikirzhytski, V.; Popova, L. A.; Lednev, I. K. Methods 2010, 52, 23 37
    40. 40
      Shashilov, V. A.; Lednev, I. K. Chem. Rev. 2010, 110, 5692 5713
    41. 41
      Permyakov, E. A. Alpha-lactalbumin; Nova Sci., New York, 2005.
    42. 42
      Redfield, C.; Schulman, B. A.; Milhollen, M. A.; Kim, P. S.; Dobson, C. M. Nat. Struct. Biol. 1999, 6, 948 952
    43. 43
      Kataoka, M.; Kuwajima, K.; Tokunaga, F.; Goto, Y. Protein Sci. 1997, 6, 422 430
    44. 44
      Kuwajima, K. FASEB J. 1996, 10, 102 109
    45. 45
      Goers, J.; Permyakov, S. E.; Permyakov, E. A.; Uversky, V. N.; Fink, A. L. Biochemistry 2002, 41, 12546 12551
    46. 46
      Kurouski, D.; Lauro, W.; Lednev, I. K. Chem. Commun. 2010, 46, 4249 4251
    47. 47
      Kurouski, D.; Lednev, I. K. Int. J. Biomed. Nanosci. Nanotechnol. 2011, 2, 167 176
    48. 48
      Sabate, R.; Baxa, U.; Benkemoun, L.; Sanchez de Groot, N.; Coulary-Salin, B.; Maddelein, M. L.; Malato, L.; Ventura, S.; Steven, A. C.; Saupe, S. J. J. Mol. Biol. 2007, 370, 768 783
    49. 49
      Mizuno, N.; Baxa, U.; Steven, A. C. Proc. Natl. Acad. Sci. U.S.A. 2011, 108, 3252 3257
    50. 50
      Sen, A.; Baxa, U.; Simon, M. N.; Wall, J. S.; Sabate, R.; Saupe, S. J.; Steven, A. C. J. Biol. Chem. 2007, 282, 5545 5550
    51. 51
      Wasmer, C.; Lange, A.; Van Melckebeke, H.; Siemer, A. B.; Riek, R.; Meier, B. H. Science 2008, 319, 1523 1526
      Kajava, A. V.; Seven, A. C. Adv. Protein Sci. 2006, 73, 55 96
    52. 52
      Benkemoun, L.; Sabate, R.; Malato, L.; Dos Reis, S.; Dalstra, H.; Saupe, S. J.; Maddelein, M. L. Methods 2006, 39, 61 67
    53. 53
      Nazabal, A.; Maddelein, M. L.; Bonneu, M.; Saupe, S. J.; Schmitter, J. M. J. Biol. Chem. 2005, 280, 13220 13228
    54. 54
      Lednev, I. K.; Ermolenkov, V. V.; Higashiya, S.; Popova, L. A.; Topilina, N. I.; Welch, J. T. Biophys. J. 2006, 91, 3805 3818
    55. 55
      Damas, A. M.; Saraiva, M. J. J. Struct. Biol. 2000, 130, 290 299
    56. 56
      Gustavsson, A.; Engstrom, U.; Westermark, P. Biochem. Biophys. Res. Commun. 1991, 175, 1159 1164
    57. 57
      Jaroniec, C. P.; MacPhee, C. E.; Bajaj, V. S.; McMahon, M. T.; Dobson, C. M.; Griffin, R. G. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 711 716
    58. 58
      Jaroniec, C. P.; MacPhee, C. E.; Astrof, N. S.; Dobson, C. M.; Griffin, R. G. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 16748 16753
    59. 59
      Kurouski, D.; Kar, K.; Wetzel, R.; Dukor, R. K.; Lednev, I. K.; Nafie, L. A. FEBS Lett. 2013, 587, 1638 1643
    60. 60
      Smith, J. F.; Knowles, T. P.; Dobson, C. M.; Macphee, C. E.; Welland, M. E. Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 15806 15811
    61. 61
      Sun, Y.; Makarava, N.; Lee, C. I.; Laksanalamai, P.; Robb, F. T.; Baskakov, I. V. J. Mol. Biol. 2008, 376, 1155 1167
    62. 62
      Khurana, R.; Ionescu-Zanetti, C.; Pope, M.; Li, J.; Nielson, L.; Ramirez-Alvarado, M.; Regan, L.; Fink, A. L.; Carter, S. A. Biophys. J. 2003, 85, 1135 1144
    63. 63
      Measey, T. J.; Schweitzer-Stenner, R. J. Am. Chem. Soc. 2010, 133, 1066 1076
    64. 64
      Welch, W. R. W.; Kubelka, J.; Keiderling, T. A. J. Phys. Chem. B 2013, 117, 10343 10358
    65. 65
      Welch, W. R. W.; Kubelka, J.; Keiderling, T. A. J. Phys. Chem. B 2013, 117, 10359 10369
  • Supporting Information

    Supporting Information


    Detailed experimental procedure, materials, and methods. Figures S1–S8. This material is available free of charge via the Internet at http://pubs.acs.org.


    Terms & Conditions

    Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html.